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ABSTRACT 
Ex press ive Writing and Br eas t Ca ncer: 
Outcomes and Linguistic Analyses 
by 
Kelly N. Hughes , Doctor of Philosoph y 
Utah State Univers ity, 2006 
Majo r Professor: Dr. M. Scott DeBerard 
Department: Psycholog y 
This project examined the imp act of an exp ressive writing intervention as 
com pared to a genera l hea lth in forma tion contro l on breast ca ncer patients ' 
postradia tion treatment. It further exami ned the co ntent of the exp ress ive wr itin g 
narratives. The samp le incl uded women who were comp let ing radiation treatment for 
lll 
breast ca nce r at the Huntsman Ca nce r Institut e and Ci ty of Hope hosp ita l. The meas ures 
utili zed in this study were se lf-r eport instruments targeting psycho log ica l distress 
(PANAS, JES) and genera l functioning (SIP), as we ll as demographic qu est ionnaires. 
Results revealed the expressive writin g interven tion sign ificantl y imp acted positive 
affect over tim e. Furthermore, participants from both the treatment and control groups 
evidenced improvements in psychological distress and general functionin g over time . 
Linguistic ana lyses revealed participants ' use of positive affect words increased across 
writing sessions, whereas the use of negative affect words and cognitive words did not 
IV 
change. Additionally, the use of past tense words decreased across writing sessions, 
whereas the use of present tense words increased and the use of future tense remained 
constant. The findings revealed from this study indicate that an expressive writing 
intervention can positively impact breast cancer patients up to 1 year postradiation 
treatment. Furthermore, the analysis of writing trends suggests that the use of positive 
affect words, the decrease in use of past tense words, along with the increase of present 
tense words across writing sessions, may be important linguistic components in positive 
outcomes . 
(180 pages) 
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CHAPTER l 
TNTRODUCTlON 
Cancer is the second leading cause of death in women (Anderson & Smith, 
2005), with breast cancer being the second lead ing cause of cancer-related deaths in 
women (American Cancer Society, 2005). A total of 2,278,269 women were diagnosed 
with breast cancer as of January of 2002 (Ries et al., 2005). Breast cancer is not only 
highl y prevalent , but rates of breast cancer have also been steadily increasin g. [ncidence 
rates of breast cancer increased 3.8% each year from 1980 to 1987 and 0.3% each year 
from 1987 to 2002 (Edwards et al., 2005). Tt is estimat ed that 212,920 women will be 
new ly diagnos ed with breast cancer in 2006 (American Cancer Society, 2006). 
Furthermore, the death rate i'rnrn breast ca11ce1· h:1s decreased 2.3°., each year l'rorn I 090 
to 2002 (American Cancer Society, 2005). 1t is apparent that more women are being 
diagnosed with breast cance r each year and more women arc also surviving this disease. 
Receiving a cancer diagnosis , particularly a breast cancer diagno sis, and 
enduring various treatment and recovery processes can be quite emotionall y distressing. 
Individuals coping with breast cancer often find themselves experiencing high leve ls of 
psychological distress (Palmer, Kagee , Coyne, & DeMichele , 2004) and decreased 
quality oflife (Beriero, 2002; de Haes & Welvaari, 1985; for review see Moyer & 
Salovey, 1996) . This psychological distress has been demonstrated to manifest in 
depression, anxiety, and trauma-related syn1ptoms. For instance , 12-37% of breast 
cancer patients have experienced a major depressive episode related to having cancer 
(Love, Kissane, Bloch, & Clarke, 2002; Manzanera, Lafay , Papet , & Senon, 2003; 
Shou , Ekeberg, Ruland , Sandvik, & Karesen, 2004). Furthermore, anxiety appears to 
affect a larger percentage of individuals with breast cancer than in the general 
population (Hjerl, Andersen , Keiding, Mortensen , & Jorgensen , 2002) , with up to 48% 
of breast cancer patients experienci ng severe anxiety symptoms (Montazeri et al., 
2000) . 
Many women further react to breast cancer as if it were a trauma . Resea rchers 
have demonstrat ed that up to 32% of individua ls exper ience posttraum atic stress 
disorder (PTSD) related to their breast cancer (Naidich & Motta , 2000) . Howeve r, 
receiving a PTSD diagnosis in the context of breast cancer appears to vary according to 
the type of asses mcnt and diagnostic too ls utilized (Kangas, Henry, & Bryant, 2002). 
Furth ermore, it has been demonstrated that experiencing intrusion and avoidance 
sympt oms related to one' s breast cancer is typically more common than meeting full 
criteria for PTSD (Alter et al., 1996; Butler, Koopman , Classen, & Spiegel, 1999; 
Cordova et al., 1995; Green, Epstein, Krupni ck, & Rolland , 1997; Koopman ct al., 
2002; McGarvcy ct al., 1998). lndividual s who experience intrusion symptom s often 
reexperience the traumatic event through thoughts or dreams , feel as if the event is 
recurring, or experience distress or physiological reactivity when exposed to reminders 
of the trauma . Avoidance symptoms are characteristic of avoiding thought s, feelings, 
people, places, conversations, and other such reminders of the distressing event. It may 
also be characterized by an inability to remember an important aspect of the trauma , 
anhedonia , feeling detachment from others , experiencing a restrict ed range of affect, or 
having the sense of a shortened future (Ametican Psychiatric Association [APA] , 2000) . 
2 
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These traumatic stress symptoms have been found to be further inversely related to 
breast cancer patients' confidence in their ability to cope with the disease (Koopman et 
al.). 
Individuals who experience trauma typically feel strong emotions (fear, 
helplessness) and struggle to work through the experience (i.e., avo id stimuli associated 
with the event, experience distressing thoughts about the event ; AP A, 2000) . Several 
trauma-related theories exist that empha size the importance of process ing the 
distress ing event in order to experience assimilation and poss ible positive increases in 
psychological and physical functioning (Chemtob, Roitblat, Hamada, Carlson, & 
Twcntyma n, 1988; Foa, Steketee, & Rothbaurn , 1989; Horow itz, 1986). Furthermore, 
studies have demonstrated that the act of disclosing thoughts and emotions can be quite 
benefic ial in reducing psychological distress. Specillcally, writing about one's deepes t 
thoughts and feelings (expressive writin g) related to a distressing event has been 
assoc iated with decreased physician visits, improved immune functioning, and 
improved psychological functioning (Francis & Pennebaker, 1992; Greenberg & Stone, 
1992; Greenberg, Wortman, & Stone, 1996; Petrie, Fontanilla, Thomas, Booth, & 
Pennebaker, 2004). 
There has been a proli feration ofr esearch over the past decade in the area of 
expressiv e writing as a treatment for traum a-related experiences. Research has 
demonstrated that written emotional expression specifically related tQ a traumatic 
experience can have a variety of positive effects on healthy population s (Dorrnelly & 
Murra y, 1991; Francis & Pennebaker , 1992; Greenberg et al., 1996; Pennebaker, 
4 
Colder, & ShaqJ, 1990; Pennebaker, Kiecolt-Gl aser, & Glaser, 1988). However, few 
studies have examined the effects of expressive writing on ill or diseased populations , 
with even fewer examining the effects of expressive writing with cancer patients, 
particularl y breast cancer patients. Researchers have demonstrated expressive writing to 
have positive effects (e.g., decrease in pain severity, better sleep qualit y, decrease in 
avo idance behaviors) on individuals vvith prostate cancer and gynecological cancers 
(Rosenberg et al., 2002 ; Zakowski, Ramati , Morton , Johnson, & Flanigan, 2004) , and 
metastatic renal cell carcinoma (de Moor et al., 2002). In terms of breast cancer, the 
effects of expre ssive writing on patient outcomes vary across studies . Of the studies that 
have c:rnmined breast cancer patients, one found the express ive writing intervention to 
have pos itive effects on physica l health outcomes, but no effect on psychological 
adjustment (Stanton et al., 2002). Another study examined the effect of expressive 
writing on psychological adjustm ent and side-effect severity , but found the intervention 
to have no effec ts on these outcomes. Unfortunat ely, the authors did not examine 
physica l health outcomes. Howeve r, they found indications in the writing samples that 
participant s found the writin g task to be helpful, sugges ting that the intervention may 
have had an effect on outcomes (i.e., physical health) that were not examined in this 
study (Walker , Nail, & Croyle , 1999). A third study examined the effect of journaling 
on breast cancer patients while simultaneously participating in a 12-week support 
group. Unfortunately, due to the simultaneous participation in a suppmi group, the 
authors could not extrapolate the unique effects of the expressive writing intervention 
on outcome (Smith, Anderson-Hanley , Langrock , & Compas, 2005) . 
) 
Despite research demonstrating various positive effects of expressive writing 
across a number of populations , very few studies have exam ined the key linguistic 
components of express ive writing that may contr ibute to improved participant 
outcomes. Uti lizing a computeri zed linguistic analysis program, researchers have shown 
that patiicipants gain the most health benefits from express ive writing if their 
compositions are made up of positive emotion words, negativ e emotion words, and 
cognitive words connoting insight , meaning, or causa l thinking patterns (Pennebaker & 
Francis, 1996; Pennebaker & Seagal, 1999). Currently, researc h is mixed with regard to 
the effect of the use of positive emotion words versus negative emotion words. For 
instance, research has demonstrated the use of negative emotion words to be associated 
with improved health outcomes (Low, Stanton, & Danoff-Burg, 2006; Pennebaker, 
1993); whereas, the use of positive emotion words is assoc iated with no health 
improvemen ts (Pennebaker). Others have found the opposite to be true, indicating the 
use of negative emotion words to be either unrelated to or negatively related to health 
outcomes and the use of positiv e emotion words to be associated with improvements in 
health (Pennebaker & Francis; Pennebak er, Mayne, & Francis, 1997). Further research 
is needed to detennine the specific linguist ic components related to improved outcomes. 
In summary, receiving a breast cancer diagnosis and subsequentl y endu1ing 
various treatment methods and recovery processes can be quite stressful and can result 
in symptoms of depression, anxiety, and posttraumatic stress. Research has 
demonstrated that the written disclosure of thoughts and emotions after a distressing 
event can have positive health consequences. Currently, there is a paucit y of research 
6 
examining the use of express ive writing interventions with breast cancer patients as well 
as litt le research in the area of linguistic content analysis of expressive writing 
exercises . The purpose of this project was to examine the effect of an expressive writing 
intervention on breast cancer patients, as well as examin e the content of the expressive 
writing natn tives to identify critical components that may acco unt for the positive 
effec ts of such writing in this population. 
CHAPTER II 
REVIEW OF LITERATURE 
7 
Th e review of litera tur e outlines resea rch conducted on the psycholo gica l 
co nseq uence s (i.e., depress ion , anxiety, po sitive and nega tive affect, and traum a-related 
sym ptoms) of rece iving a breast cancer diagnosis and enduring treatment for the 
disease. The negative effects of experiencing a life-threatening disease will be explor ed, 
includin g theori es related to cognitive proc ess ing and emotional ex pressio n. Resea rch 
pertaining to the use of expressive writin g, as a means of increas ing emotio nal 
ex press ion , and its effec ts will also be outlined. Finally, research exam inin g the specific 
co mponents of express ive writing narrativ es that are related to outcome will be 
reviewed. 
Breast Ca nce r and Psyc holog ica l Distress 
Receiving a breast ca nce r diagnosis and enduring ens uin g treatment and 
recovery proc esses are assoc iated with a high leve l of emotional distress. Women with 
breast cancer may feel helpless and hop e less abo ut the future (Pettin ga le, 1984), have 
low se lf-esteem (Ander so n & Johnson, 1994) , and deve lop negati ve bod y ima ge 
(Moyer, 1997). Women may furthe{ experience distress from fear of death (Vick berg, 
2003), pain (Maunsell, Brisson, & Deschenes, 1993), fear of cancer recmTence 
(Figueiredo, Fries, & Ingram, 2004; Vickberg) , and general unpredictabilit y of the 
future (Voogt et al., 2005). This psychological distress is often manifested through 
depression , anxiety , or generally low positive mood. Due to advances in detection and 
8 
treatment, mor e and more women are surviving this pervasive disease and may strugg le 
to cope with assoc iated physical and psycholog ical distress (Win go, Tong, & Bolden, 
1995) . The increased survival rate illustrat es the need for interven tions that target the 
distress assoc iated with having and surviving breast cancer. 
Depression and Anxiety 
Several factors make diagnosin g depression in cancer pati ents diffi cult. First 
and primaril y, depression can be difficult to accurately detect in this popul ation du e to 
commonl y overlappin g physical symptom s of depression and cancer. Specificall y, the 
Diagnostic ancl Stotistical Ma1111al of Mental D isorders -Fourth Editio n-Tex/ Revisio n 
(DSM- IV-TR; Amer ican Psychiatric Assoc iation, 2000) cr iteria for a major depressive 
episode includes physical symptom s such as !~1liguc, psyc homotor retardation 0 1· 
agita tion, insomnia or hypersomnia, and weight loss or ga in. These sympt oms may also 
be exper ienced as the result of having cancer and endurin g various cancer treatment s 
(American Cancer Soc iety, 2006). The follow ing preva lence studies that are discussed 
did not spec ify whether they adjusted for phys ica l sym ptoms related to cancer versus 
those related speci fica lly to depression. 
Several studies have examined the preva lence of depression and anxiety in 
general cancer patients (i.e., breast , prostate , lymphom a, neck; Berard, Boerm eester, & 
Viljoen, 1998; Ciarame lla & Poli , 2001; Derogatis et al., 1983; Hotopf, Chidgey , 
Addington-Hall, & Ly, 2002; Ritterband & Spielberger , 2001) , with fewer studies 
exa mining depression and anxiety rates in breast cancer patients specificall y. Available 
resea rch has demonstrated that depression and anxiety rates in breast cancer patients 
9 
(29-37%; Burgess et al., 2005; Epping-Jordan et al. , 1999; Love et al., 2002; Manzanera 
et al., 2003; Shou et al., 2004) can be several times the rates found in the general 
population (5-9%; American Psychiattic Association , 2000) and may be related to 
mortality risk for breast cancer patients (Hjerl et al., 2003). However , varying rates of 
psychological morbidit y are repo11ed for this population . Several factors contribute to 
different rates of depress ion and anxiety in breast cancer patients, including stage of 
treatment ( diagnosis , treatment , recover y), type of treatment (lumpectomy , 
mastectomy), stage of breast cancer (early versus late stage cancer; see Table 1), 
primary versus recunent breast cancer , age, and assessment measure utilized (Epping-
Jordan et al.; Fallowfield, Hall, Maguire, & Baum, 1990; Hopwood, Howell, & 
Maguire, 199 1; Kissane et al., 2004 ; Montazeri et al., 2000; Pinder, Ramirez, Richards, 
& Grego ry, l 99-+; Tibbs, 2003 ). 
Researchers provide conflicting findings (see Table 2) with regard to changes in 
rates of depress ion and anxiety from the time breast cancer is diagnosed to the 
posttreatment period (Shou et al., 2004; Tibbs , 2003). Depression in breast cancer 
patients near the time of diagnos is ranges from 22-34% (Epping-Jordan et al., l 999; 
Monta zeri et al., 2000; Shou et al.). Epping-Jordan and colleagues examined depression 
and anxiety rates in breast cancer patients within an average of 11 days after being 
diagnosed with cancer and again at 3- and 6-months postdiagnosis. They utilized the 
Symptom Checklist-90 Revised (SCL-90R), a self-report measure of psychological 
distress that includes a depression and anxiety scale. They found 34 % of breast cancer 
patients experience depression symptoms in the clinical range based on the SCL-90R. 
10 
Table I 
Breast Cancer Stage 
Stage Definition 
Stage O - earliest form of breast cancer 
- cancer ce lls located within a duct that have not penetrated into surroundin g fatty tissue or 
Stage I 
Stage Tl 
Stage lfl 
lobules 
- cancer has not spread to distant sites 
- tumor s?c m and has not spread to axillary lymph nodes 
- cancer has not spread to distant sites 
- no tumor is in the breast, but it is in I to 3 axillary lymph nodes 
- or, tumor s? cm and has spread to l to 3 axillary lymph nodes 
- or, tumor is 2cm-5cm and has or has not spread to axillary lymph nodes 
- or. tumor :25cm but has not grown into the chest wall or spread to axillary lymph nodes 
- cancer has not spread to distant sites 
- tumor ~5c m and has spread to --+ to 9 axillary lymph nodes or to interna l mamma ry nodes 
- or. tumor > 5cm and has spread to I to 9 axillary lymph nodes or to internal mammary 
nodes 
- or. tumor has spread into the chest 11·all or skin and has spread to Oto 9 a:--illary lymph 
and may have spread to internal mammary nodes 
- or, tumor is any size and has spread to either 10 or more ax illary lymph nodes, I or more 
lymph nodes under or over the clavicle, or to internal mammary lymph nodes 
- cancer has not spread to distant sites 
Stage IV - late stage breas t cancer 
tumor can be any size and has spread to distant organs (bo ne. li\'l:r. lung) or lO lymph 
nodes far from the breasta 
a American Cancer Soc iety, 2006 
Depression rates decreased at 3 and 6 months postbreast cancer diagnosis with 29% and 
- 26% experiencing clinical range depression symptoms , respectively. At the time of 
diagnosis , 40% noted significant anxiety symptoms, which decreased to 18% at 3 
months , and then increased -to 21 % at 6 months postdiagnosis . Montazeri and colleagues 
(2000) examined depression and anxiety in women 3 months after receiving a breast 
cancer diagnosis utili zing the Hospital Anx iety and Depr ession Scal e (HADS). The 
Table 2 
Depression and Anxiety in Breast Cancer Parienzs 
Authors 
Burgess et al. 
Cohen 
Epping-Jordon et al. 
Fallowfield et al. 
Hopwood et al. 
Jenkins, May, & 
Hughes 
Year 
2005 
2002 
1999 
1990 
1991 
1991 
Measures 
Structured Clinical 
Interview for 
DSM-Il!R (SCIO) 
SCL-90R 
SCL-90R 
"standard methods" 
HADS & RSCL 
CIDI, HAS, 
MAD RS 
II Rares of distress 
202 Depression, anxiety. or both: 
1-5 years after diagnosis: 4 %, 25%, 23%, 22%, 15%, respectively
with breast cancer recurrence: 45%
80 Recurrent breast cancer patients obtained significantly higher scores on anxiety and depression 
subscales than non recurrent bre::ist cancer patients. 
110 3-lo/o clinical range depression symptoms at diagnosis, 29% at 3 months, 26% at 6 months 
postdiagnosis 
269 
21-l 
-l0% clinical range an:-.iety symptoms at diagnosis, 18% at 3 months, 21 % at 6 months postdiagnosis 
Depression: 
Mastectomy: 29"" following surgery 
27% at 3 months postsurgery 
21 % at I year postsurgery 
Lumpectomy: 22% following surgery 
15% ::it 3 months postsurgery 
19% at I year postsurgery 
HADS: 9% depressed: 17% borderline 
9% anxious: .5% borderline 
9% depressed and anxious; I% borderline 
RSCL 22% met cl 1n1cal cutof
f 
for psychological morbidity 
I 8% depressed 
I .\'!lo anxious 
14°10 both depressed and anxious 
(table continues) 
Authors Year Measures II 
Kissane et al. 2004 MILP, HADS 503 
Manzanera et al. 2003 HADS 
Montazeri et al. 2000 HADS 151 
Pinder et al. 1993 HADS 139 
Early stage breast G111cc1· 
37%depressive disorders: 
Rates of distress 
I 0% major depressive disorder, 2% dyshymic disorder, 25% adjustment disorder with 
depressed or 1rn xed depressed/anxious mood 
9'Yo anxiety disordc1-s: 
2% general11cd anxiet) disorder, I% panic disorder, 2% PTSD, 
4% adjustment disorder with anxious mood 
Late stage breast c:mccr 
32%depressivc disorders 
7% major dcixessive disorder, 2% dysthymic disorder, 23% adjustment disorder with 
depressed 01 1rnxed depressed/anxious mood 
7° 0 anxiety disorders 
2% generali1cd anxiety disorder, 0% panic disorder, I% PTSD, 
4% adjustment disorder with anxious mood 
Early stage cancer patients (89% breast cancer) 
32% depressed 
13% major depressive disorder, 19% adjustment disorders 
30% anxious 
15% agoraphobia, 9% generalized anxiety disorder, 6% panic disorder 
3 months after diagnosis 
22% depressed: 14% borderline depressive symptoms 
48% anxious; 29° " border! me anxiety symptoms 
Ad,·anced stage breast cancer 
12% depressed 
19% anxious 
(table continues) 
10 
Authors Year Measures II 
Shou et al. 2004 HADS 165 
Tibbs 2003 CES-D 79 
Time of diagnosis: 
12% depressed 
34% anxious 
3 months after breast surgery: 
6% depressed 
2-1% anxious 
year after breast surgery: 
9% depressed 
26% anxious 
At radiation treatment complCllun: 
29% depressed 
Rates of distress 
2 weeks after radi:.111011 treatment completion: 
23% depressed 
6 weeks after radiation tre::llment completion: 
28% depressed 
\.,J 
14 
HADS is a self-report meas ure w ith two subsca les (depr ess ion and anx iety). Scores of 
11 or mor e on either subsca le indicate a significant case of depre ss ion or an x iety and a 
sco re of 8 to l O indicat es depress ion or anxiety in the borderlin e c lin ica l ran ge . They 
found a lower depression rate in breast ca nce r pati ents, with 22% experiencing 
significant depress ive symptoms. They further found 14% were experiencing depr ess ive 
symptoms in the borderline clin ical range. With rega rd to anx iety, 48 % report ed 
c lini ca lly signific ant symptoms and 29% reported ex periencin g bord erline symptoms. 
Tibbs (2003) was int eres ted in the ps yc ho log ical adjustment o f wo men after completing 
radi ation tre atm ent for breast cancer. She measured depr ess ion throu gh the Center for 
Epidemiologirn! Studies - Depressio n Scale (CES-D), a se lf-r eport mea sure of 
depress ion that signifi es c lini ca lly signi Ii cant depre ss ive symptom s when a sco re o f 16 
o r above is ob ta ined. She found 29% o[ wo men expe rienced depres s ion at the encl or 
trea tm ent , wh ich decreased at 2 weeks posttr ea tment (23%) and then increas ed (28 %) 
by their follow-up medica l appo intm ent 6 wee ks posttr ea tment. Finall y, Shou and 
co lleag ues (2004) report ed cha nges in dep ress ion and anxiety in women with breast 
ca nce r at the time of di ag nos is and 3 and 6 month s after surgery. Ut iliz ing the HADS , 
th ey found 12%, 6%, and 9% of wome n to experienc e c lini ca lly sign ificant depress ive 
sy mptoms and 34%, 24% , and 26 experience sign ificant anx iety at diagnosis , 3 months 
postsurgery, and 6 months postsurgery , respectively . 
Depression rates in breast cancer pati ents at the end of tre atment range from 22-
30% with most ev idenci ng a decrease in symptoms up to 1 year po stt rea tment 
(Fallowfield et a l., 1990; Tibbs , 2003). Tibbs examined the preval enc e of depr ess ion in 
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patients who had completed surgery or radiation treatment and who were enter ing the 
survival phase of breast cancer. She found depression to decrease 2 weeks after 
treatment completion , but then increase almost 6 weeks later near patients' follow-up 
doctor appointment. Approximately one third of participants experienced clinically 
significant symptoms of depression at the end of radiation treatment as well as 6 weeks 
later. Fallowfie ld and colleagues examined depression rates in women with breast 
cancer immediately after completing breast surgery and 3 and 12 months after surgery. 
They found women who underwent a mastectomy to evidence a downward trend in 
depress ion rates, with 29% exper iencing depress ion after surgery, 27% at 3 months , and 
21 % experiencing depressive symptoms at I year postsurgery. With regard to women 
who underwent a lumpectomy, depression rates decreased from the time immediatel y 
following surgery (22%) to 3 months later ( I 5%) and then increased at l year 
postsurgery ( 19%). The differences in depression rates between patients who underwent 
mastectomy versus those who underwent lumpectomy were not found to be 
sign ificantly different. 
Regarding breast cancer stage, Kissane and col leagues (2004) found that early 
stage (stage I or IT) and late or advanced stage (stage IV) breast cancer patients 
experience similar rates of depression and anxiety, with adjustment disorders being the 
most common diagnoses . They utilized the Monash Interview for Liaison Psychiatry 
(MILP; a structured psychiatric interview for medically ill patients used to diagnose 
mood, anxiety, and substance abuse disorders) and the HADS. They found 37% of early 
stage patients to have a depressive disorder (9.6% major depressive disorder , 2.3% 
l6 
dysthymic disorder , 24.8% adj ustm ent disorder with depresse d mood or mixe d 
depressed /anxious mood) , and 9% with an anxiet y diso rder (2% ge nera lized anxiety 
disorder , I% panic disorder, 2% PTSD , 4% adjustment disord er with anxious mood) 
approximately 3 months after breast surgery. With regard to late stage breast cancer 
patients , 31 % had a depr essive disord er (6.5% major depressiv e disorder , 1.5% 
dysthy mic disorder, 23% adju stment disorder with depresse d mood or mixed 
depressed /anxious mood) , and 7% had an anxiety diso rder (2% ge nera lize d anxiety 
disorder, I% PTSD , 4% adjustmen t diso rder wit h anxious mood) 63 months after 
receiving their cancer dia gno sis. Manzanera and colleagues (2003) found slightly lower 
rate s of depression (32% total = l 3% major depressive disorder, 19% adjustment 
disorders) in ea rly stag e cancer patient s (wome n w ith breast cancer repres ented 89% of 
participants) and much higher rates of anxiety (30% tota l = l 5% ago raphobia , 9% 
ge nera lized anxiety disorder, 6% pani c disorder) utili z ing the BAD S. Hop woo d and 
co lleag ues ( l 99 l) found lower rat es of depression and simil ar rates of anxiety in 
adva nced stage breast ca ncer patients. Based on sco res from the I-IADS, they found 9% 
of women with advanced stage breast cancer expe rienced dep ression, 9% expe rienced 
anxiety , and 9% experienced anxiety and depression (total of 27% with psyc holog ica l 
morb idit y). They found fewer women (22%) were identified as exper iencing 
psychological morbidity based on scores from the Rott erdam Sy mptoms Checklist 
(RSCL; a self-report measure of quality of life that includes a subscale pertaining to 
psychological symptoms). Finally , Pinder and colleagues (1993) repotied 12% of 
advanced stage breast cancer patients to meet the clinical cutoff for significant 
depressive symptoms using the HADS and 19% with significant anxiety symptoms. 
Breast cancer recurrence has also been assoc iated with depression and anxiety 
symptoms in women (Cohen, 2002; Jenkins et al., 199 1). Cohen utilized SCL-90R to 
examine psychological distress in breast cancer patients. She found individuals with a 
recurrent diagnosis of breast cancer to have significantly higher scores on depression 
and anxiety subscales of the SCL-90R as compared to women with a primar y and 
localized (stage I or II) breast cancer diagno sis. Jenkins and colleagues found 46% of 
women with recutTent breast cancer to experience psychological morbidity. They 
specifically found participant s were "psychologically ill" with depression (18%), 
anx iety ( 14%), or both depression and anx iety ( 14%). The identification of 
psychological morbidity was based upon results from the Composite International 
Diagnostic Interview (CLDl; structured assessment of psychological illness), the 
Montgomery Asbe rg Depression Rating Scale (MADRS; a self-report measure of 
depression), the Ha111ilto11 Anxiety Scale (HAS; a self-report measure of anxiety), and 
the Eyse nck Perso nality in ventory (EPI; a self-report measure of personality 
characteristics). 
In addition, breast cancer patients who are older tend to experience lower levels 
of depression and anxiety as compared to their younger counterparts (Kissane et al., 
2004; Pinder et al., 1994; Tibbs, 2003) . Specifically, women over the age of 55 have 
been found to report fewer symptoms of depression than women under the age of 55 
(Tibbs). Women with early stage breast cancer who are diagnosed with a depressive 
disorder are also significantly younger on average (47.6 years) than women who are not 
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depressed (53.2 years; Kissane et al.). In addition , being under the age of 50 has been 
found to be associated with the development of a persistent (lastin g more than 6 weeks 
after being diagnos ed with breast cancer) depressiv e and/or anxiety disorder (Pinder et 
I 
al.). 
Positive and Negative Affec t 
Depression and anxiety have historically been difficult to distinguish, as they are 
highly comorbid and strongly associated with each other (Fawcett & Kravit z, 1983; 
Murphy et al., 2004). They share common symptom s (e.g., irritability , sleep 
disturbance, psychomotor agitation/ restlessness, fatigue, difficulty concentrating), 
which contributes to their comorbidity (American Psychiatric Association , 2000). Self-
report measures of depression and anxiety have further been found to be highly 
co1Telated (Dobson, 1985), demonstrating their sympt om overlap and difficult 
discrim inability. Dobson found significant corre lations (range = .3 7-.86) between five 
self-report measures of depression and four self-report measures of anx iety, suggest ing 
the difficult y in discrimin ating between these two constructs. Some suggest depression 
and anxiety lie on the same continuum (Angst & Dobler-M ikola, 1985) or represent 
sub factors of a larger internalizing disord er model that includes all depressive (major 
depressive episode, dysthymia) and anxiety (generali zed anxiety disorder , social phobia, 
simple phobia, agoraphobia, panic disorder) disorders (Krueger, 1999). 
Research suggests that positive and negative affect represent the primary 
dimensions of the majorit y of self-report measures of mood (Watson & Tellegen , 1985). 
Positive affect is characteri zed by attention , activity, and interest level. High positive 
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affect indicates overall enjoyable interaction with one's environment or excitement, 
determination , high activity, and pride. Low positive affect reflects low energy and 
fatigue. Overall , negative affect is associated with general distress , hostility , fear, guilt, 
nervousness, and iJTitability (Watson, Clark, & Tellegen, 1988b). 
Researchers have examined the relationship between positive and negative 
affect and depression and anxiety and have found them to be correlated (Crawford & 
Henr y, 2004; Watson et al., 1988b). Research demonstrates high negative affect to be 
reflect ive of anxiety and the combination of high negative affect and low positive affect 
to be related to depression (Boon & Peeters, 1999; Watson , Clark, & Carey, l 988a). 
Spec ifically, Watson and colleagues found negative affect to be significantly correlated 
with 55% (median r = .22) of anxiety symptoms (including symptom s of panic disorder, 
phobias, and obsessive compulsive disorder) and 95% (median r = .33) of depressive 
symptoms (both with correlations ranging from .20 to .57). They further found negative 
affect to be significantly positively correlated with any depress ive diagnosis (.51) and 
any anxiety diagnosis (.32) based on the Diagnostic interview Schedule. Positive affect 
was found to be significantly negatively corTelated with any depressive diagnosis (-.38), 
but was not significantly related to any anxiety diagnosis except social phobia (-.23). 
Crawfo rd and Henr y reported similar findings. They examined the relationship between 
positive and negative affect and depression and anxiety utilizing the Depression 
Anxiety and Stress Scales (DASS) and the Hospital Anxiety'. and Depression Scale 
(BADS). Results indicated positive affect was more strongly negatively coJTelated with 
depression (r = -.48 to -.52) than anxiety (r = -.30 to -.31) and negative affect was 
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strongly positiv ely correlated with both depression (r = .44 to .60) and anxiety (r = .60 
to .65). Jolly , Dyck, Kramer , and Wherry ( 1994) found additiona l evidence of a strong 
negat ive relationship betwee n positive affec t and depress ion (r = -.61), a weaker 
relationship between positive affect and anxiety (r = -.39) , and a strong positive 
relationship between negative affect and depression (r = .77) and anxiety (r = .75). 
Unlike the overlap between depression and anxiety, positive and negative affect 
have been estab lished as distinct const ructs of psychological functionin g with relatively 
little overlap (Watso n, Clark, & Carey, 1988a) . This finding lead to the deve lopment of 
a self-repo rt measure (Pos itive and Negative Affect Scale; PANAS) that specifically 
measures these constructs and is viewed as a more discrimin ate measure of affect ive 
state (Watson, Clark , & Tellegen, I 988b). The PANAS is a se lf-repor t measur e 
consist ing of two subscales , pos itive affect (PA) and negative affect (NA), each made 
up of IO items. The directions instruct individuals to respond to each item in a way that 
indicate s how they have been feeling over a spec ified period of time (e.g., in the past 
few days , over the past 2 weeks). Each item is rated on a Lickert sca le of 1 (not at all; 2: 
a little; 3: moderately; 4: quite a bit) to 5 (extre mely; Watson et al., 1988b). PA in the 
general population ranges from 29. 1-36.2 and NA ranges from 14.8-22. 1, depending on 
the time period spec ified in the instructions (e.g., how do you feel in the present 
moment, how do you generally feel; Crawford & Henry , 2004; Watson et al., 1988b). 
Since the development of the PANAS , research ers have set out to determine if 
the PA and NA subscales of the PANAS are, in fact, independent constructs. During the 
deve lopment and validation process of the PANAS , Watson and colleagues (l 988b) 
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report ed a small ne gative corre lati on betw ee n PA and NA subscal es (r = -.12 to -.23 , 
over six occa s ions of measurement). Schmukle, Eg loff , and Burns (2002) examined trait 
("how do yo u fee l in genera l, that is, on average") and state (" ho w do you feel right 
now , that is, at the present moment ") PA and NA in under gra duate universit y students. 
They found that trait PA and A are ind ependent, but state PA and NA are slightl y 
negatively corr e lated (r = -. 16 to -.27 over thr ee occasions of measurement) . Mehrabian 
(1997) found a similar negative correlation (r = -.12) between state PA and NA in an 
und ergraduat e uni ve rsit y student population. Th e highest corre lat ion betw ee n state PA 
and NA was -.30, and was found in a ge nera l adu lt population in the Un ited Kin gdom 
(C rawfo rd & Henry , 2004). Ove rall, research has demonstrated the PA and NA 
subsca les of the PANAS to ev idence ver y littl e over lap and to represe nt relati ve ly 
distinct co nstru cts (Schmukle et a l.; Watson et al., I 988b). 
Few resea rch ers hav e exa mined PA and NA in indi viduals with cancer and 
parti cular ly in indi vidu als w ith breast cance r. However , so me emerge nt trends are 
evident. Voogt and co lleag ues (2005) exa min ed PA and NA in advanced stage cancer 
patient s. They found PA to be low er in individuals w ith advanced stage cancer than 
individuals in the genera l population. How eve r, they found NA to be comparable to that 
of the ge neral population. They suggest that psychological distress characterized by 
depression and anxiety may be largely related to low PA, as opposed to high NA as 
found in psychiatric populations (Boon & Peeters, 1999). Walker, Nail, Larsen, Magill, 
and Schwartz ( 1996) examined PA and NA in individuals with early stage, locali zed 
breast or prostat e cancer at 20 months postradiation treatment. They found these 
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indi vidu als to have relati ve ly high po sitive affec t (M = 38. 7) in com pariso n to the 
ge nera l popul ation but comparable nega tive affect (M = 17.0 ). fn ano ther stud y with 
stage I or II br eas t ca ncer pati ents , Walker and co lleag ues (1999) found simil ar leve ls of 
positiv e (M = 36 .6) and negative affect (M = 17.7). Wh en examining the qu ality of life 
in wo men with breast cancer , Andrykowski and colleagues ( 1996) found mean po sitive 
affect leve ls (3 3.6) to be relatively low er , but consistent w ith the ge neral popul at ion 
(C rawford & Henr y, 2004; Watson et al., 1988 b) . 
Trcwnw-Related Symptoms 
The re has bee n a pro Ii feratio n of resea rch in the area of PTSD in breas t ca ncer 
pati ents particularly sinc e the DSM- JV-TR (APA, 2000) added life-thr eateni ng illn ess as 
a poss ible strcsso r that could result in suffi c ient trauma to lead to a PTS D dia gnos is. In 
o rder to obtain a diag nosis of PTSD , one must hav e bee n ex po sed to a traumatic eve nt 
that invo lved act ual or thr ea tened death , injury , or thr ea t to one's ph ys ica l \\'Cl I-being, 
and the indi vidu al's response must be characterized by helpl ess ness, fear , or horror. 
Dia gnos tic crit eria for PTSD further requir es the ex perience of at leas t one intru sion 
sy mpt om (i.e ., rec urrent distr ess ing thou ghts, ima ges , or percept ions, rec urr ent dreams , 
feeling or behav ing as if the eve nt were recurring, distr ess when ex pos ed to reminders 
of the eve nt , ph ysiological reactivity when exposed to reminders of the event), at leas t 
three avoidance syrnptoms (i .e., avoidance of thoughts , feelings, or conversations 
related to the event, avoidance of activities, places , or people that serve as reminders of 
th e event, inability to remember an important part of the eve nt, decreased int erest in 
ac tiv ities, feeling detached or estranged from others, ex periencing a decreased range of 
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affect, feeling as if one's future is shortened), and at lea st two symptoms of 
hyperaro usal (i.e ., trouble fall ing or staying asleep , in-itabilit y, difficu lty concentrating , 
hyper vigilance , ex aggerated start le response). Furthermore , these symptoms must e licit 
signific ant distress in one's socia l, occupational, or -other area of functioning and must 
last for mor e than 1 month (AP A, 2000). 
Despite having established relatively agreed upon criteria for PTSD, rates of this 
disorder in individuals with breast cancer tend to vary great ly depending on several 
factors, includin g which diagno stic tool is utili zed. Kangas and coll eag ues (2002) 
conduct ed a rev iew of literature on studies of cancer-related PTSD , including studi es 
spec ifica lly exa minin g breas t cancer pati ents. The rev iew of brea st ca ncer studies wi 11 · 
be discussed here. Th e majorit y of studi es utili zed a cross-sectiona l des ign and 
exa min ed pati ents 2 month s to 12 yea rs postprimar y trea tment for breas t cancer. Kang as 
and co lleag ue s reported rate s of PTSD to vary accordin g to diagno stic instrum ent 
utili zed. Resea rchers us ing the PTSD C linica l [ntervi ew for DSM-IV (SCID) found 
incidence rates ranging from 0-9% (Andrykowski, Cordova, Studts , & Miller , 1998 ; 
Mund y et al. , 2000; Palmer et al., 2004). Those utili z ing the cut-off method (score of at 
least 50) with the PTSD Check list C ivi lian Version (PCL-C), a self-report measure of 
PTSD , found incidence rates ranging from 5-12% (Andrykowski & Cordova, 1998; 
Andrykowski et al., 1998; Cordova et al., 1995; Jacobsen et al., 1998) , whereas those 
utili zing the symptom cluster method (focuses on the required number of specific 
symptoms) with the PCL-C found incidence to range from 6-19% (Andrykowski & 
Cordova , 1998 ; Andrykowski et al. , 1998; Jacobsen et al.). Higher rates of PTSD (14%-
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32%) were found in indi vidual s with breas t cancer when using the C linician 
Administered PTSD Scale - Structured lnt erview (CAPS-I; Naidich & Motta , 2000; 
Pitman et al., 200 1 ). Incid ence rat es of PTSD also appear to be higher in individuals 
w ith middl e- to advanced-sta ge (stage II-IV) breast cancer (Jacobsen et al.) as compared 
to ea rly- to middle-stage (stage 1-JIIA) br eas t cancer (Andrykowski & Cor do va, 1998; 
And rykowski et a l., 1998; Co rdo va et al. , 1995) . Other research ers found low er rates of 
PTSD ( 4%) in breas t cancer pati ents when using the SCID and further found younger 
wo men to be mor e likely to res pond to their breast cancer diagnosis w ith inten se 
helpless ness, fear, o r horror (Pa lmer et a l., 2004). 
Kangas and co lleag ues (2002) summ arized seve ral st udi es that exa min ed 
intru sion and avoida nce sympt oms in breas t ca ncer pati ents utili z ing the Imp act of 
Eve nts Sca le (!ES). The I ES is a se lf-report meas ure of subj ec tiv e di stress that 
spec ifica lly exa min es the ex peri ence of intru sive thou ghts or emotions("! thought about 
it when I didn ' t mean to"; "An y remind er brou ght bac k fee lings abo ut it") and 
avo idance beha viors (" I tried to remove it from my memo ry"; " l tri ed not to talk abo ut 
it") in re latio n to a specific stresso r, like br east canc er. Ov erall , 5-52 % of br east cancer 
patients evi denced high (score ~O) intrusion and avoidance symptoms (Butler et al., 
1999 ; Tjems land , Soreide , & Malt, l 996a , l 996b, 1998) . Furthermore , resea rch ers have 
found subclinic a l ( experiencing symptoms of PTSD consistent with two of the three 
symptom categories - intrusion , avoidance, hyperarousal) rates of PTSD in 5-13 % of 
breast cancer patients (Andrykowski & Cordova, 1998; Andrykowski et al., 1998). 
Koopman and colleagues (2002) examined intrusion and avoidance symptoms in 
stage l to III breast cancer patients who had received their breas t cancer diagnosis 
within the past year. They found 12% scored in the clinica l range (score 220) on the 
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intrusion subscale and 27% scored in the clinical range on the avoidance subscale of the 
lES. 
Wide variation has been noted in incidence rates of breast cancer-related PTSD. 
This variation appears to be influenced by a number of methodol ogical factors, 
including the use of cross-sectional versus longitud inal study designs, the use of 
di fferent assessme nt measures (structured interviews versus self-report), and the use of 
retrospective data (Kangas et al., 2002). Participant factors also seem to influence rates 
of PTSD in this population, including stage of breast cancer (Jacobse n et al., 1998), age, 
and mar ital status (Tjerns land et al., l 996a). It is importan t to note that research has 
demons trated prev ious Ii fe stressors to increase the likelihood of deve loping trauma 
symptoms related to a current traumatic event, whether that traumatic event be the 
diagnos is of breast cancer (Ba ider, De-No ur, & Atara, 1997) or othe r traumatic event 
(Ullman & Siege l, 1994), which may further compl icate this clinica l picture. 
It is apparent that many individuals with breast cancer evidence trauma-related 
symptoms (i.e., intrusion, avo idance) at least at a subsyndrom al yet significant level. It 
seems that the confounding factors related to determinin g whether a woman has actual 
breast cancer-related PTSD are outweighed by the overwhelming finding that many 
wom en with this disease experience significant trauma-related distress and could benefit 
from intervention. 
Concfusio11s: Psyc hologi cal Distress 
and Breas t Cance r 
Research has demonstrated that breast cancer patients often experience 
significant psychological distress throughout their expe1ience with cancer. Many 
women with breast cancer experience significant related psychological distres s, 
including depression , anxiety , PTSD, low PA, and intrusion and avoidance symptoms . 
Rates of psychological distress vary according to various methodological ( e.g., 
assessment measure used, cross-sectional versus longitudinal data) and particip ant 
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factors (e.g., breast cancer stage, primary versus recurrent breast cancer, type of cancer 
treatment, age, marital status). Additionall y, researchers have explored alternative ways 
to describe and measure psychological distress that avo ids the necess ity of a disease or 
illness label, spec ifically through the examination ofposi ti\C and ncgati\e affect (i c .. 
PANAS) and trauma-related symptoms (i.e., intrusion , avo idance). It is obvious that a 
large number of individuals diagnosed with breast cancer often struggle with significant 
levels of distress at various times after disease diagnosis, treatment, and recovery. 
Therefore, psycho logical interventions to help alleviate such distress in breast cancer 
survivors are warranted . 
Disclosure 
Theoretical Implications 
Disclosure refers to the act of expressing thoughts and emotions , which can 
occur through verbal (talking) or nonverbal ( e.g., writing) means. Several theories exist 
to help explain changes that can occur during the disclosure process, which help 
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indi vidu als to bet ter cope w ith psyc ho log ica l dist ress, includin g traumatic ex periences. 
Most theo ries depict distressing or traumatic ex peri enc es as being incongruent with a 
perso n 's schema or cognitive repres entation of safety and well-being (Hollon & Kriss , 
1984 ; Horowit z, 1986). Some postulate that a fear network or traumatic memor y 
network is formed as a res ult of the distr ess ing eve nt (Cr eamer, Bur gess, & Patt iso n, 
1992; Foa et a l., 1989). The trauma ma y furth er challenge the indi vidual 's view of the 
self and /or of the world ( e.g., good thin gs happ en to goo d peopl e and bad things happ en 
to bad peopl e, the world is a ju st place) leav ing one in a ge neral state of conflict with no 
wa y of making se nse of or und erstandin g the distressing eve nt (Resick & Schnicke , 
1996). To optim ize hea lth and we ll-being, the individual mu st proce ss the trauma tic 
expe rience in order to ass imil ate it into one's ex istin g cog nitiv e schemata. Pr eex isting 
sc hemata mu st also be modified to accom moda te the inco ngruent in form at ion acc rued 
from processin g the distressin g ex perience (Chemtob et a l., 1988 ; Foa et al. ; Horowit z). 
fn orde r to adeq uate ly proc ess and make se nse of such a distress ing and cog niti ve ly 
inco ngruent eve nt, one must express thoughts and emotions re lated to the eve nt 
(Ne meroff et al., 2006). Foa and Jayco x ( 1999) found that negat ive though ts and the 
tend ency to avo id thoughts and emotion s re lated to a trauma is common imm ediately 
fo llo wing a traum atic event. However, individuals who continue to avoid their trauma-
related thoughts and emotions are at higher risk to developing PTSD . The active 
concealment of distressing personal infonnation from.nthers has also been found to be 
corre lated with anxiety and depression (Ichiyama et al., 1993; Larson & Chastain, 
1990). Conversely, the expression of one's thoughts and emotions related to a traumatic 
experience has been found to be physically and psycholog ically beneficial (Frisina, 
Borod, & Lepore, 2004; Smyth, 1998). 
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Pennebaker and Beall (1986) posited a theory that relates inhibition to 
physiological and disease processes. Inhibition is defined as the failure to talk, write, or 
think about a personally distressing event. They discuss the inhibition of behaviors , 
thoughts, and feelings as physiologically taxing the body . The physiological demands 
that inhibition places on the body can exert cumulativ e stress over time. The resultant 
physiologica l stress can increase the likelihood of developing a stress-related disease 
(see Selye, 1978). Research has since support ed this inhibition theory. Specifically, 
inhibiting one's thoughts and emotions can have immediate physiolog ical effects on the 
body by increas ing autonomic activity as measured by skin conductance leve ls and 
heart rate (Hughes, Uhlmann, & Pennebaker, 1994). Furthermore, it has been associated 
with more long-term cumulative effects, such as negative health consequences (e.g., 
increases in physician visits, increased illness; Pen_nebaker, 1999; Pennebaker & 
Susman, 1988), decreased immune functioning (Pennebaker et al., 1988; Petrie, Booth, 
& Pennebaker , 1998; Petrie et al., 2004), increased psychological distress (Bryant, 
Moulds, Guthr ie, Dang, & Nixon, 2003; Donnelly & Murra y, 199 1; Foa, Rothbaum, 
Riggs, & Murdock, 1991), neoplastic disease (Jamner, Schwart z, & Leigh, 1988), and 
poor disease course in cancer patients (Epping-Jordan , Campas , & Howell , 1994; 
I ensen, 1987). The converse has also received support as disclosure has been associated 
with improved health as well as a reduction in ruminations (Pennebaker & Susman) . 
Disclosure and Breas t Cancer: Patt erns 
and Effects 
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Few studies have examined disclosure patterns in breast cancer patients, but the 
available research sheds some light on expression tendencies in this population. 
Henderson , Davison , Pennebaker , Gatchel, and Baum (2002) specifica lly examined 
degree of disclosure (not at all, a little, somewhat, very much) related to one's breast 
cancer experience. They found that the majority of women discussed their disease at 
least somewhat, but 15-23% disclosed only a little with family members, medical 
personnel, or friends . Some breast cancer patients did not discuss their diseas e at all 
with family (8%), medical personnel (6%), or friends (8%). With regard to desire to 
discuss their breast cancer, more than half indicated at least a moderat e desire. 
However, 19~~> indicated not wanting to talk about their expe rience at all and 12% 
wanting at least somewhat to keep their breast cancer a secret. 
Stanton and colleagues (2000) assessed the predictive power of emotionall y 
expressive coping on psychological and physical adju stment to breast cancer. They 
examined stage I and II breast cancer patient s (N == 92) at an average of20 weeks 
postbreast cancer treatment (i.e., surgery, chemotherapy, radiation). Data were again 
collected 3 months later. Outcome measures utilized included the COPE (coping skil ls 
related to having breast cancer, including avoidance behaviors), the Hope Scale 
(behaviors related to goals), FACT (health related quality of life), POMS (psychological 
distress, vigor), perceived health , and number of medical visits. Participants , who 
reported coping by expressing their cancer-related emotions, evidenced fewer medical 
appointme nts, an increase in perceived physical health and vigor (POMS), and a 
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decrease in distress as compared to participants who reported low emotional expression. 
Furthem1ore, for individuals who indicated having receptive social support, emotionally 
expressive coping was related to increased quality of life (FACT). Howev er, individual s 
who expressed an avoidant coping style evidenced an increase in distress and a decrease 
in positive emotion at the 3-month follow-up . 
Other researchers were interested in the effects of the inhibition of emotional 
expression in individuals with breast cancer. Servaes, Yingerhoets , Vreugdenhil, 
Keuning, and Broekhuijsen (1999) examined potential differences in the inhibition of 
emotional expression between breast cancer patients and healthy controls. They found 
that breast cancer patients exhibit greater emot iona l constraint and ambiva lence about 
emo tional express ion than contro ls. However, breast cancer patients did not differ trom 
controls on their willingness to talk with others about their emo tions, their overall 
propensity to express emotions, and alexithymia. lwamitsu , Shimoda, Abe, Kodama, 
and Okawa (2003) specifically studied the effec t of emot ional inhibition (i.e., failure to 
express negative emotions) on overall distress leve l. They found that the inhibition of 
negative emotions, as measured pre- and postbr east cancer diagnosis, was related to an 
increase in emotional distress (e.g., anxiety, depression) after being diagnosed with 
breast cancer. It appears that individuals who have a tendency to restrain emotional 
expression, experience higher levels of distress when diagnosed with breast cancer as 
compared to individuals who express their-emotions. Additionally, the inhibition of 
negative affect and an overall repressive personality style have also been related to the 
spread of breast cancer (Jensen, 1987). Finally , others have found high negative 
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affectiv ity and high emoti onal constraint to predict sho rtene d survi va l tim e in recrnTent 
breas t cancer pati en ts (Weihs, Enrig ht , Simmens, & Reiss, 2000). 
Many women with breas t cancer appear to express thoughts and emotions 
related to their diseas e experience (Henderson et a l, 2002). How eve r, some women do 
not express themse lves and act ive ly inhibit negative emotions (He nd erson et al.; 
Iwamitsu et a l., 2003; Weihs et a l., 2000). Not disclosing one's thoughts and feelings 
related to their breast cancer experience has been demonstrated to have deleterious 
effects on indi vidu als and has spec ifica lly been associated with the spread of cancer and 
with an ea rlier death (Jensen , 1987; Weihs et al.). Converse ly, the ac t of expressing 
one's thoughts and emotion s related to their exper ience of cancer has been 
demons trated to have pos itiv e physica l and emotional consequences (de Moor et a l., 
2002; Low et al., 2006; Rosenbe rg et al., 2002; Stanton ct a l., 2002; Walker et al., 1999; 
Zakowski et a l., 2004). The follow ing outlin es litera tur e perta inin g to the effects of 
ex press ing one's thou ghts and emotions within the context of express ive writin g. 
Expressive Writing 
Over th e past 20 yea rs, research examinin g the effec ts of disc losure through 
express ive writ ing as a treatme nt for distressing experie nces has proli fera ted . 
Pennebaker and Beall (1986) were pioneers in this area. They developed an expressive 
writing research paradigm that many researchers have.utilized ( e.g., de Moor et al., 
2002; Norman, Lumley, Dooley , & Diamond , 2004; Petrie et al., 1998; Rosenberg et 
al. , 2002). First , participants are random ly assigned to either an expressive writing 
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group (express deepest thoughts and feelings related to the traum a) or a control 
condition (write about facts surroundin g a trauma or trivial subjects). Participants in the 
expressive writing group are then instructed to write for a relativ ely short period of time 
(i.e., 20 to 30 minutes) for 3 to 4 days. They are instructed to write about an 
experienced traumatic or "t ragic emotional event" (Petrie et al.). Other studies have 
instructed participants to wr ite about a specific distr ess ing experience such as chronic 
pelvic pain (Nonn an et al., 2004) or cancer (Rosenberg et al., 2002). Since Pennebaker 
developed this express ive writing paradigm, many subsequent researchers have 
examined its effec ts on both healthy populations and populations with either acute or 
chronic illnesses (e.g., cancer , rheumato id arthri tis). While this review of literature will 
include previous rc,·icws of studies involving health y participants, the primar y focus 
will be on studies examining cance r patients. 
Pre1•ious Re1·ie11·s of Erpress ive IVriting 
Literatur e 
Two systematic reviews of expressive writing literature have been publi shed. 
One review examin ed express ive writing studies that utilized physica lly and 
psychologic ally healthy particip ants (Smyth, 1998), whereas the other examined studies 
that utilized participants with physical or psychiatric disorders (Frisina et al., 2004). 
Smyth ( 1998) conducted a systematic review of literature examining written 
emotional expression and its effect on health. He specifically examined randomized 
experiments that utilized the written emotional expression intervention developed by 
Pennebaker and Beall (1986). He further only included studies that utilized physicall y 
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and psychologically healthy participants , and studies that instructed a treatment group to 
write about traumatic events and a contro l group to write about innocuous events. 
Additionally, studies included in the review utilized an outcome measure of health 
(mental , physica l, general functioning) and provided sufficient infomrntion to calcu late 
effect size. Smyth found 13 studies that met these criteria. He calculated an overa ll 
effect size of d = .4 7, indicating a 23% improvement in overall health and well-being . 
He further calculated an effect size for each outcome, which included reported health 
(d = .42; i.e., health center visits, self-reported symptoms, upper respiratory illness), 
psychological well-being (d = .66; i.e., positive and negative affect , anxiety, etc.), 
physiological function ing (d = .68; i.e., T-he lper lymphocytes, blood pressure, 
cholesterol , etc.) , general functionin g (d = .33; i.e., grade point average, absenteeism , 
reemployment, etc.) and health behaviors (d = .03; i.e., alcohol/drug use, exercise, 
sleeping habits, etc.). All outcome effect sizes were found to significant ly differ from 
zero, with the exception of health behaviors. Several covariates were examined. 
Specifical ly, neither the number of writing sessions (I to 5) nor the length of each 
writing session ( 15 to 30 minutes) were associated with the overall effec t size; however, 
the period of time within which the writing session took place (1 to 28 days) was related 
to the overall effect size, but was not specifically related to psychological wel l-being or 
physiological functioning. Being asked to write about past, current, or past and current 
traumas was not related to the overall effect size. However, higher mean psychological 
well-being effect sizes were found for patiicipants who wrote about current traumas and 
higher mean physio logical functioning effect sizes were found for participants who 
wrote about either past or CL!ffent raumas as compared to those who wrote about past 
traumas only. The percentage of male participants was also found to be positively 
associated with the overall effect size, whereas age was not. 
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Frisina and colleagues (2004) conducted a meta-analysis of written emotional 
disclosure with clinical populations. Inclusion criteria included utilizing partic ipants 
with a physical or psychiatric illness, an experimental design , Pennebaker and Beall's 
(1986) expressive writing task (or some close variant), a quantitative measure of 
physical health, mental health, health behaviors, or general functioning, and sufficient 
data to calculate effect sizes. The authors found nine studies that met these criteria. An 
overall effect size was calculated for each study and for each outcome type and then 
averaged across studies and outcome types to yield a significant overal l mean effect size 
of d = .19, p < .05. Five of the nine studies utilized physical health outcome measures, 
which produced an overall effect size of cl= .21, p = .01. Eight of the nine studies 
utilized psychological health outcome measures , which produced a nonsignificant effec t 
size of d = .07, p = . l 7. Despite not finding a significant overall effect for psychological 
outcome, specific mental health outcomes indicated participants evidenced 
improvements in the areas of depression (Beck Depression Scale, Automatic Thoughts 
Questionnaire , Symptom Checklist-90), anxiety (Perceived Stress Scale), mood 
(PAN AS-Positive Affect, Profile of Mood States), and sleep quality (Pittsburg Sleep 
Quality Index) ~ 
Based on the respective reviews, physically and psychologically healthy 
individuals appeared to not only generally have benefited from writing about a 
35 
traumatic or distressing experience, but also benefited specifically in reported health, 
psychological well-being, and physiological and general functioning. Psychologicall y 
and physicall y ill populations also significantly benefited from such an intervention but 
to a marginal degree. They evidenced significant improvements in physical health, but 
not in overall psychological well-being. The failure to find a significant effect on 
psychological well-being may in part be due to the inclusion criteria the various studies 
utilized. The studies that examined psychiatrically ill populations did not exclude 
participants if they were participating in psychotherapy or taking medications for their 
psychiatric illness. The simultaneous participation in other treatments made it difficult 
to disentangle the uniqu e impact of the exp ress ive writing interve ntion on outcomes 
(Frisina et al., 2004). 
Expressive Writing with Cancer 
Populations 
Research involving pariicipants with cancer will be exa mined in more detail , 
followed by studies specifically o f breast cancer patient s. 
Other cance rs. de Moor and colleagues (2002) examined the effects of 
express ive writing on late stage (stage IV) metastatic renal cell carcinoma (kidn ey 
cancer) patients as compared to a neutral wtiting control (N = 42) . The treatment group 
was instructed to write about their deepest thoughts and feelings related to their cancer 
during four writing sessions. The control group (neutral writing group) was instructed to 
write about various health behaviors (i.e., diet , sleep, physical activity). Psychological 
and behavioral adjustment were assessed , utilizing the Impact of Events Scale (IES; 
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intrusive thoughts and avoidant behaviors), Perceived Stress Scale (PSS; self-reported 
stress), Profile of Mood States (POMS; tension-anxiety , depression-dejection , anger-
ho stility , confus ion-bewilderment, vigor, fatigue), and the Pittsburg Sleep Quality Index 
(PSQI; subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep 
disturbances, use of sleeping medication, daytime dysfunction). Follow-up data were 
co llect ed on the da y of the last writing session and at 4, 6, 8, and 10 weeks 
posttreatment. The majority of participants were male (86%) and had an average age of 
56. No differences between the treatment and control groups were found on 
ps ychological adjustment measures of IES, the PSS , and the majority of the subscales 
on the POMS with the exception of the vigor subs ca le on which the express ive writing 
group repo rted sig nifi ca ntly higher levels of vigor. However, significant differences 
were found between the treatment and control gro up on the PSQl, with the treatment 
group ex periencin g less sleep disturbance , better sleep quality, increased time spent 
sleep ing, as wel l as less daytime dysfunction. 
Rosenberg and co lleagues (2002) conducted an ex pre ss ive writing study with 
prostat e cancer patients (N = 30). Participants were randomi ze d to either an expressive 
writing disclosure group or a nondisclosure control group. The treatment group 
similarly wrote on four different days for 20 to 30 minutes about either their experience 
with cancer or other traumatic life experience. All participants were male and had a 
mean age of 70. Outcome measures included the National Medical Care Utilization an.d 
Expenditure Survey, immune function and disease markers (prostate-specific antigen 
[PSA] va lues , peripheral blood T-cell proliferation, serum cytokine levels) , Brief Pain 
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Inventory (BPI), Medical Outcomes Study-Short Fom1-36 (MOS-SF-36), Functional 
Assessment of Cancer Therapy Scale-Prostate (FACT), Symptom Checklist-90 Revised 
(SCL-90-R), Brief POMS, Rumination Scale, and the Ways of Coping-Cancer Version. 
Follow-up outcome data were collected at 3- and 6-months posttreatment. Again , results 
indicated no differences between treatment and control groups with regard to 
psychological outcome measures (SCL-90-R, Brief POMS , Rumination Scale, Wa ys of 
Coping-Cancer Version), quality of life (MOS-SF-36, FACT), and disease and 
immunocomp etence measures. However. results indicated a trend toward lower number 
of health care contacts and reduced medication use for the treatment group. 
Furthermore, level of pain severity remained unchanged over time for the treatment 
group (mild pain), but worsened for the control gro up (from mild pain at baseline, to 
mod erate pain at 3 months, to severe pain at 6-month follow-up). 
Zakowski and colleagues (2004) examined the effect of written disclosure on 
participants with prostate or gyneco logical cancers (uterine, ovarian, cervical). They 
were specifically inter este d in determining whether the expressive writing intervention 
would serve to buffer soc ial constraint effects on distress. They defined social constraint 
as perceived insufficient social support that results in hesitation or unwillingness to 
express thoughts and feelings to others as related to a stressful event, like cancer. They 
argued that individuals with social constraints thus may not have the opportunity to 
process distressing experiences. Participants were randomly assigned to either an 
expressive writing condition (n = 62), where they wrote about their deepest thoughts 
and feelings related to the cancer experience across 3 consecutive days, or to a control 
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condition (n = 42), where they wrote about daily activities without expressing emotions 
or opinions. Approximately half of the participants were female (52%) and had a mean 
age of 60. The researchers assessed changes in social constraint (Social Constraint 
Scale) and psychological distress (Brief Symptoms Inventory , IES). Follow-up data 
were collected 6-months posttreatment. Findings revealed no significant chan ges in 
distress levels (BSI scores) or level of social constraint for the treatment group. 
However , treatment group participants who reported high levels of social constraint at 
baselin e exhibited distr ess levels (BSI scores) comparabl e to individuals with low leve ls 
of social constraint at follow-up. Individuals in the control group , who reported high 
leve ls of social con straint , subs equ ently report ed high leve ls of distre ss at the 6-month 
follow-up . An alyse s furth er indicated no e ffect o f express ive writin g on intru s ive 
thoughts. How ever, indi viduals in the treatm ent group reported relative ly fewer 
avoidance behaviors than control participants at th e 6-month follow-up. 
Breast cancer. Walk er and collea gues ( 1999) conducted a pilot stud y exa minin g 
the effects of expres sive writing on breast canc er patients as compared to a usual care 
control group (no writing). They were specificall y int erested in the psycho social effect s 
of expressive writing, as well as determining if this intervention would have a dose-
related effect , with more disclosure opportunities leading to increased effect. 
Participants had early stage breast cancer (stage I or II) and were in their last week of 
radiation trnatment. Mean age was 54. Participants were randomly assigned to either 
one of two expressive writing groups or a usual care control group (n = 16). One 
expressive writing group was instructed to write about their deepest thoughts and 
feelings related to their cancer experience one time (11 = 12), whereas the other 
expressive writing group wrote about their experience on three consecutive days 
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(n = 16). Psychosocial adjustment was measured with the PANAS (state and trait 
forms), the IES , and the SEC (Side Effect Severity Checklist). Follow-up psychological 
functioning data were collected 1 week, 4 to 6 weeks, 4 months, and 7 months 
postradiation treatment. Results indicated expressive writing intervention did not 
significantly impact psychological adjustment (PA and NA, intrusion and avoidance 
symptoms) of participants. The authors hypoth es ized that this may have been due to the 
small sample size and thus, low statistical power. Despite having no effect on 
psychological functioning outcomes, many participants indicat ed the expressive writing 
expe rience to be he lpful both in their writings and at a follow-up interview. Participants 
spec ificall y commented on the writing providing them with a means to express 
emotions they thought might be taxing for others to hear about, helping to sort out 
patiicular concerns and identify prioritie s, and being generally helpful. 
Stanton and colleagues (2002) examined effects of an expressive writing 
intervention (deepest thoughts and feelings related to breast cancer experience) as 
compared to a benefit finding (positive aspects of breast cancer experience) and control 
(facts about the cancer experience) condition. They utili zed participants (N = 60) who 
had early stage breast cancer and were no more than 20 weeks postmedical treatment 
(i.e., surgery, chemotherapy, radiotherapy). All three conditions entailed writing for 20 
minutes across four writing sessions (within a 3-week time period), with the difference 
being the topic about which the participants wrote (thoughts and feelings about breast 
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cancer experienc e, benefits of the cancer experience, and facts related to the 
ex peri ence). Follow-up data were collected 1- and 3-months postintervention. Analyses 
revea led no significant effects on psychological outcomes (POMS, FACT) for any of 
the thTee groups. The authors speculate that this may have been due to participants 
reporting overall higher quality of life and lower levels of distress as compared to breas t 
cancer patients in other studies. Significant differences between groups were ob tained 
for phys ical health outcomes (negative somatic symptoms, number of medical v isits) . 
Spec ifica lly, the exp ress ive writing gro up ev idenced a significantly fewer physical 
sym ptoms (mean = 17), as well as had fewer medical appointments (mean = 0.40) 
related to their breast cancer as compared to the benefit finding (phys ica l symp toms: 
mean = 22; medical appointments: mean = .90) and co ntrol gro up s (p hysica l symptom s: 
mean = 30; medical appointm ents: mean = 2.20) at 3 months post treatmen t. Fina lly, 
participants who wrote about their deepest thou ghts and feelings and indi ca ted low 
cancer-rela ted avo idance expe rienced a decrease in distress. How eve r, those who 
indi cated a high leve l of avoidance ev idenced a higher leve l of distress at I -month 
follow-up. This trend pers isted thrnugh the 3-month follow-up per iod. 
Low and colleagues (2006) examined data from Stanton and colleagues (2002) 
to determine the means by which such an expressive writing intervention was related to 
decreased physical symptoms and medical appointments . They specifically analyzed 
mediator effects (i.e., heart rate, postwriting mood) on group variables. Heart rate 
habituation during the writing session was greatest for the expressive writing condition 
(mean = 16. 78 , SE= 1.52, p < .05) as compared to the benefit finding and control 
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conditions. Fwihermore, within writing session heari rate habituation mediated the 
effects of the expressive writing intervention on physical symptoms. Participant mood 
immediately following expressive writing had no significant impact on the overall 
group effect. The authors indicate these findings suggest the decrease in autonomic 
nervous system arousal that occurred after engaging in an expressive writing exercise, is 
related to the processing of emotions associated with a difficult past experience. 
Conclusio ns: Disclosure 
According to two meta-analyses of related express ive writing literature, it 
appears that expressive writing has sign ificant and meaningful effects on healthy 
individuals as well as on physically and psychologica lly ill individuals who experienced 
a distress ing e\·cnt. Positive effec ts were found for reported health, psychological well-
being, and physiological functioning for healthy participants. Spacing writing sessions 
across a longer time period (i.e ., 1 week between each writ ing session versus 24 hours 
between each session); being male seem to increase the magnitude of positive effects 
for healthy individuals. Furthermore, significant positive overall effects for physical 
health were found for physically and psychologically ill peop le. 
The three studies located pertaining to the use of expressive writing with cancer 
patients provides somewhat limited findings due to the relatively small sample sizes. 
However, overall it appears that health outcomes (medical contacts, sleep, medication 
use) are positively impacted by the expressive writing intervention and that 
psychological outcomes are not impacted by the intervention. Thus it is clear that more 
research in this area is needed. 
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Content Analysis of Express ive Writing Essays 
As discussed previously , expressive writing can have positi ve psychological and 
health outcomes for health y populations and positive health outcomes for ill or diseased 
populations. The next important question to examine is: what are the linguistic variables 
of the expressive writing exerc ise that are related to improved outcom es? This question 
was originally posited by Pe1mebaker (1993) who was interested in detem1ining why 
expressive writing is related to positive health benefits . He arrived at this important 
question only after first exam ining the topic about which par1icipants wrote. He found 
that when instructin g participants to write about a distr essing event, they differed not in 
the topic they wrote about, but in the manner within which they wrote or expressed 
themse lves. For example, two of his study participant s both wrote about problems they 
had with a roommate ; however, one merely listed the roommate 's character flaws, 
whereas the other participant examined conflict with the roommate in a self-reflect ive 
manner (Pennebaker). Other researchers have reported si 111 iI ar differenc es, including the 
finding that participants who express significant emotio n experience increased immune 
function as compared to those who do not express emotion when disclosing (Esterling , 
Antoni, Kumar , & Schneide1man , 1990). Thus , Pe1mebaker was interested in 
detem1ining to what degree specific words, people choose to use to express their 
thoughts and feelings, help to induce positive benefits of disclosure. 
Few studies have examined the linguistic content of expressive writing essays. 
Furthermore the majority of studies that performed content analyses utilized healthy 
participants (Pennebaker, 1993; PenJ1ebaker & Francis , 1996; Pennebaker et al., 1997). 
One study examined participants with kidney cancer (de Moor et al., 2002), and two 
examined participants with breast cancer (Low et al., 2006; Walker et al., 1999). The 
most common linguistic content variables examined across studies, included negati ve 
emotions (i.e., sad, anxious, angry), positive emotions (i.e., happy, relief, joy), and 
cognition, which consists of insight , causal, and self-reflective words (i.e., reali ze, 
understand, because). 
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Researchers utili zed the Linguistic Inquiry and Word Count program (LIWC; 
Francis & PenJ1ebaker, 1993) , which was recently updated (Pennebaker, Francis, & 
Booth, 2003), to analyze the linguistic content of expressive writing essays. The LIWC 
was origina lly developed to exam ine wr itten or spoken passages from indi vidual s who 
had exper ienced a trauma or genera lly distressing event. [ti s a text analysis program 
that processes many different categories of words including those related to emo tions 
(positive and negative) and cognition (causal- and insight-related words). This pro gram 
ana lyzes text by searc hing for words that are categorized w ithin its dictionary file. The 
dictionary tile for the original LIWC program contained over 2,000 words or word 
stems that made up 61 specific word categories (i.e., positiv e emotion words, cognitive 
words). The program was designed to examine a text document and detem1ine the 
percentage of words within selected language dimensions in relation to the entire text 
document. The dictionary in the LIWC program was developed by compiling a list of 
words from thesaurus, emotion-related questionnaires, dictionaries , and groups of 
judges. After compiling the set of words, a minimum of two judges must have confe1Ted 
independently as to which word category (i.e., negative emotion words) each word 
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should be plac ed. Th e words were then ex amin ed for a second time, and at least three 
new judges had to reach agreement on the inclusion of words within a broader category 
(Pennebak er & Francis , l 996). The purpose of using such a program to analy ze the 
linguistic content of express ive writing essays related to a distressing event is to help 
determin e if spec ific writing styles (e.g., using positiv e emotion words, cognitiv e 
words) lead to impro ved outcomes. 
Pen11ebaker (1993) examined the linguistic content of expressive writing essays 
from thr ee pre vious studi es (Penn ebak er, 199 l , as cited in Pennebak er, 1993; 
Pennebaker et al., 1988 , 1990) in order to explore wh y writing can be advantageous. 
Afte r analyz ing a numb er of diff erent linguisti c dim ens ions, he found that participants 
who ev idenced hea lth imp roveme nts utili zed a large r proportion of nega tive emot ion 
wo rds (i. e., anxiety , sad ness) than positiv e emotion words as compared to particip ants 
who did not impro ve . Pennebaker futiher found that the participants who improved 
ev idenced simil ar total numb ers of cog niti ve pro cess ing words as the partic ipant s who 
did not impro ve. However , parti c ipants who impro ved pro gresse d from using fewe r 
cog niti ve processing words in the first writin g sess ion to mor e cognitive pro cess ing 
wo rds by the las t writin g sess ion . Expressing nega tiv e emotion as well as evidencing 
cognitive processing is consistent with most trauma theori es that suggest emotional 
expression and cognitive processing, or assimpation of traumatic experiences, are 
necessary to make sense of and positively cope with distressing events (Chemtob et al..., 
1988 ; Foa et al. , 1989 ; Horowit z, 1986). 
Pennebak er and Francis (1996) obtained some contrary conclusions to 
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Penn ebak er 's prev ious finding s. Specifically, they found negative emotion words to be 
unr e lated to changes in health outcomes. Furthermore, the use of positive emotion 
words was relat ed to better hea lth outcomes. With regard to cognitive processing , 
similar results to Pennebaker (1993) were found with increased cognitive processing 
across w riting sess ions leading to positive hea lth outcomes. 
Pennebaker and colleagues (1997) reanal yzed data from six existing studies that 
utili ze d langua ge va riabl es as health predictors. Participants included college students 
(Pennebaker & Francis, 1996; Pennebaker et al., 1988, 1990) , medical students (Petrie, 
Booth , Pennebaker, Davison , & Thomas, 1995) , maximum-security male inmates 
(R ichards , Pennebaker, & Beall, 1995, as cited in Pennebaker et a l., 1997), and 
unemployed male professionals who had been laid off from their jobs (Spera, 
Buhrfeind, & Pennebaker, 1994). The authors found the use of more nega tiv e emotion 
words in relation to positive emotion words to be associated with negative outcomes. 
This is in direct co nni ct w ith Pennebaker's ( 1993) ea rlier findin gs. The authors further 
found the use of more positive emotion words 111 re lation to fewer nega tive words to be 
related to better hea lth. This is similar to results Pennebake r and Francis obtained, 
which indicated that the use of positive emotion words are related to better health 
outcomes. A regression analysis using adjusted distress as the outcome revealed that 
participants who reported greater distress at follow-up used more death-related and 
positive words and used fewer past tense verbs and unique words as compared to 
participants experiencing less distress. With regard to cognition, the increased use of 
cognitive processing words from the first day of writing to the last was associated with 
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decreased physician visits and reported physical symptoms , as well as impro ved grades 
and gaining employment. 
de Moor and colleagues (2002) exam ined the linguistic content of express ive 
writing essays in participants with kidney cancer. Unfortunatel y, they did not provide 
details of this analysis . The authors noted the expressive writing essays to be 
significantly different from control essays on 24 of 32 different word categories , 
includin g affective, cognitiv e, and socia l processing. They provided no mor e 
explanation of findings. 
Walker and co lleagues (1999) conducted the most app licab le experiment to the 
curre nt project. They exam ined the linguistic content of narratives writte n by patients 
with breast cancer. The authors did not comment on the relationship of linguistic 
components to outcome, as the expressive writing intervention was not found to be 
significantly related to outcome. Howev er, the authors reported writing trends for the 
exp ress ive writing treatment group. They computed paired r tests to assess change in the 
percentage of words across various categories from the first writing sess ion to the third. 
Walker and co lleagues found a significant increase in words related to general affect 
and decreases in words pertaining to metaphysical concerns (death, religion) as well as 
words related to body functions and states. They did not spec ificall y examine cognitive 
processing words . 
The most recent study to examine the linguistic content of expressive writing 
narratives also utilized a breast cancer population . Low and colleagues (2006) examined 
the linguistic content of narratives from participants who were either instructed to write 
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about their deepest thoughts and feelings related to their breast cancer experience 
(genera l disclosure) or write about the benefits of their cancer experience (benefit 
finding). General writing trends included an increase in the use of positive emotion 
words across writing sessions for both groups, a decrease in negative emotion words 
across sessions for the general disclosure group , and greater use of cognitive words for 
the general disclosure group as compared to the benefit finding group. They found no 
significant changes in the use of cognitive words across writing sessions for either 
treatment group. 
Co11clusio11s: Linguistic Analyses 
Due to the smal I number of studies and heterogeneous sample populations in 
this area of research, the lo llo\\·i11g su111111ary should be considered preli111inary. O,·era ll, 
studies demonstrated the expression of negative and positive affectiv e words to lead to 
better outcomes. Unfortunat ely, conflicting findings were found with rega rd to the 
effect of the percent of negative words expressed in relation to the percent of positive 
words expressed. Additionally , the increased use of cognitive words across writing 
sessions resulted in increased positive outcom es. This is the most consistent finding 
acros s studies. Cognitivel y proces sing the events of a trauma is thought to be necessary 
for cognitive assimilation , understanding , and overcoming traumatic experiences 
(Chemtob et al., 1988; Foa et al., 1989; Horowitz, 1986). 
Summary and Objectives of the Current Project 
Cunent literature indicates the diagnosis and treatment of breast cancer to be 
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quite distressing for many women. Research has further demonstrat ed expressive 
writing to have positive effects for some healthy individuals who have experienced 
distressing or traumatic events. Although limited, research suggests expressive writing 
positively impacts physical health outcomes in women with breast cancer. Additionally, 
resea rchers have begun to explore specific linguistic components of expressive writing 
narratives that are related to positive outcomes. However, there is a relative dearth of 
literature in the area of expressive writing in breast cancer patients , as well as linguistic 
analyses of such writings. The current project examined the effec t of an expressive 
writing intervention on breast cancer patients, as well as examined the content of the 
exprcss i\'e writing narrati ves to identify critical components that may facilitate the 
positive effects of such writ ing in this population. The following questions were 
addressed by this project: 
I. Does an expressive writing intervention impact positiv e affect, negative 
affect , intrusion and avo idance symptoms , or genera l functioning as compared to a 
genera l health information controJ? 
2. What are the relationships between the use of positive words, negative words, 
cognit ive words, and verb tense across the three writing sessions with positive affect, 
negative affect, intrusion and avoidance symptom s, and general functionin g? 
3. Is perception of prior disclosure at baseline related to intrusion and avoidance 
symptoms, positive affect , negative affect, or general functioning at baseline and 
follow-up? 
CHAPTER Jil 
METHOD 
Data Collection 
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This study utilized a portion of an extant data set collected tlu-ough a grant from 
the National Institute of Nursing Research (ROI NR0457l-02) at The University of 
Utah awarded to Lillian M. Nail, R.N., Ph.D., principal investigator (Appendix A). The 
or iginal study was a randomized clinical trial utilizing a three-group design. The 
investigators were interested in determinin g the effectiveness of two primar y 
interventions designed to facilitate the coping process follo,ving radiation therapy for 
breast cancer . The concre te objective info1111ation intervention (not utilized in the 
current project) intended to address side effects or symptoms and unexpec ted 
experiences of breast cancer patients. Its aim was to improv e patients' confidence, 
understanding, and abi lity to app ly spec ific strategies and accurate expectat ions 
regard ing side effects, symptom s, and experiences related to the completion of radiation 
therapy. The expressive writing intervention (EW) addressed negati ve cancer-related 
thoughts and emotions that are often inhibited. The aim of this intervention was to 
reduce inhibition of cancer-related thought s and emotions through linguistic expression. 
The concrete objective information and expressive writing interventions were derived 
from self-regulation theory and designed to target postradiation treatment coping 
processes in women with breast cancer. Specifically, the concrete objective information 
intervention targeted instrnmental coping and the expressive writing intervention 
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targeted emotional coping. The expressive writing intervention involved instructing 
participants to write about their deepest thoughts and feelings related to their cancer and 
cancer treatment (Appendix B). They were told to write for 30 minut es on three 
different days over the following 5 days (e.g. , write today, skip a day, and write on the 
following two consecutive days). 
The third treatment group, general health information (GHI), provided 
information to participants that might typicall y be offe red to patients by their health 
care prov iders and \\·as conside red a treatmen t as usual control. This intervention 
entailed participants listening to a tape recording on the final day of their radiation 
therapy (Appendix C). They were further instructed to rcviC\\' a pamphlet that contained 
the same informat ion as provid ed on the tape recording on the follow ing two clays. The 
hea lth information provided to participant s was obtained from common patient 
education material s found in cancer treatment facilities. The information spec ifically 
included a description of changes in radiation treatment side effects that are often 
experienced after the completion of such a treatment, thoughts and fee lings women 
experience following treatment , cancer resources, as well as posttr eatment medical 
information. The description of side effect change s included info1111ation about dry or 
peeling skin , numbn ess, fatigue , hot flashes, and difficult y sleepin g. Inform ation related 
to thoughts and feelings focused on a description of conunon patterns of thinking or 
feeling , including thinking about cancer and cancer treatment when one did not intend 
to, experiencing feelings about cancer and cancer treatment after encountering a 
reminder or trigger , and feelings of dereali zation or emotional numbness. With regard to 
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cancer resources , participants were provided contact information (i.e., telephone 
numbers , internet add resses, street addresses) for the Amer ican Ca nc er Soc iety and 
NCI, and were encouraged to access cancer info1111ation ti-trough local public libraries , 
bookstores , and librari es at co lleges and universities. They were also advised to write 
down contact information for their radiation treatm ent facility and doctor , as well as the 
spec ifics of their diseas e (i.e ., type of cancer, date of diagnosis, date treatment was 
completed). Addit iona lly, the GHI group was provided w ith info1111ation about expected 
follow-up doctor visits and hov,, to get the most out of those v isits. They were further 
provided with genera l infonnation on taking advantage of health insurance coverage 
and how and where one co uld volunteer her time working with others who have cancer 
if she so desired. 
The primary goa ls of the current proj ec t was to exami ne the effect iveness of 
Pennebaker and Beal l's (1986) ex pressive writing intervention with breast cancer 
patients and to analy ze the I inguistic content of written narrati ves. The proj ect was 
modeled after existing ex pressive writing literatur e that compared an ex pressiv e writing 
treat ment group to either a benign writ ing group (e.g., write about facts of an event , 
objective ly describe an object or event; Booth , Petr ie, & Pennebaker, 1997; Pennebaker 
& Beal , 1986; Pennebaker & Francis, 1996; Stanton et al., 2002) or treatment as usual , 
nonwriting control group (Richards, Beal, Seagal, & Pennebaker, 2000; Rosenberg et 
al., 2002; Walker et al., 1999). Therefore, the-current project examined only two (EW 
and GHI gro ups) of the original study's thr ee treatment groups. The rationale for 
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exc luding the concrete objective infonnation treatment group was based on the premise 
that it was outside of the scope of an expressive writing intervention study. 
Patients completed baseline measures 1 week prior to their comp letion of 
radiation therapy and were then randomi zed to either the concrete objective 
information, EW, or GHI conditions. Instructions for the interventions were then 
provided during the patients' final radiation therapy appointment. 
In the original study, the decision to study the effects of this treatment 
postrad iation therapy completion was made as a result of research indicat ing this can be 
a stressfu l time for cancer patients. After completing cancer treatm ent, many individuals 
hzive unexpected intrusive thoughts about their cancer expe rience, avoid reminders of 
their cancer (Walker et al., 1996), and avo id thinking about their cancer (Jarrett, 
Ramirez, Richards, & Weinman, 1992) . Furthermore, patients have indicated the often 
more intense social suppoti that was present during their diagnosis and treatment 
declines and fear of cancer recurrence increases (Maher, 1982). It was because of the 
potential for experiencing stress that it was determined the postrad iation treatment 
period would be well suited for such an intervent ion. 
Participants 
The target population for the study consisted of women receiving curative 
radiation therapy for breast cancer. Participants were recruited from Huntsman Cancer 
Institute in Salt Lake City, Utah, and City of Hope in Duarte, California. In order to 
participate in the original study, participants were required to meet several criteria, 
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including being at least 21 years of age, receiving curative radiation therapy for stage l , 
ll, or III breast cancer, being able to speak, read, and write English, being able to 
engage in self-care activities independently, and having no known substance abuse 
problems. Participants fu1iher could not at the time of the study be receiving psychiatric 
services or have a history of cognitive deficit. Data collection took place from July 1998 
through December 2000. 
A total of 275 breast cancer patients were recruited for the original study and 
randomized to one of the three treatment groups, concrete objective infom1ation, EW, 
and GHI. The current project examined the EW treatment group (N = 89) as compared 
to the GHf control group (N = 9 1 ). Baseline data for one GHI group participant was lost 
due to research error . Therefore, this subject was dropped from all analyses, leaving 90 
participants in the GHl control group (Figure !). Furthermore, 1-week follow-up 
outcome data was not obtained from one treatment group participant, as a result of 
being unable to contact that person, and from one control group participant for an 
unknown reason. Follow-up data at 4 weeks, 6 months, and I year postradiation 
treatment were not obtained for two EW group participants due to the participants 
requesting to drop out of the study at the 4-week follow-up. One-year follow-up data 
were also not obtained from seven EW group parti cipants (six due to inability to contact 
them, one due to an unknown reason) and from two GHI group participants ( due to 
inability to contact them). Finally , two EW participants and one GHI group participant 
were deceased by the I-year follow-up from cancer-related complications , which 
precluded the collection of further data from those pariicipants. 
EW =8 9 
Follow-Up 
I week = 88 
4 weeks= 87 
6 months= 87 
1 year= 78 
Participants 
GHI = 90 
Follow-Up 
I week= 89 
4 weeks= 90 
6 months= 90 
I year = 87 
Figure 1. Particip ant profile graph depict s the participant profile from baseline tl1rough 
the I-year follow-up. 
Measures 
Data were collected through seve ral self-report measur es. Participant s 
spec ifically completed a genera l screening form, a demographic form, two measures 
assess ing psychological distress , one measure of general functioning , and an assessment 
of prior disclosure (Appendix D). The following outlines descriptions and psychometric 
properties of each assessment instrument as well as a description of the linguistic 
analysis program utilized. 
Participant Screening Form 
The Participant Screening Form was made up of questions related to participant 
inclusion criteria . Specific questions pertained to general contact information , breast 
cancer diagnosis and treatment, primary language, psychiatric care, substance abuse, 
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independence of self-care, living environment (i.e., institutional setting), and cognitive 
functioning . 
Demographic Data 
General demographic data (e.g., age, ethnicit y, education level, marital status, 
employment) were obtained directly from participants through a demographic 
question_naire. Information pertaining to their breast cancer (e.g., stage of disease) was 
obtained from medical records. 
Positive and NA Schedule 
(PANAS) 
The PANAS, as developed by Watson and colleagues (1988), is a 20-item 
assessment that measures the principal dimensions of mood, and positive and NA. lt is 
comp rised of two 10-item subscales, the PA subscale and the NA subscale. PA is 
described as atten tive, interested , alert, exci ted, enthusiastic, inspired, proud , 
determined, strong, and act ive. NA is described as distressed, upset, host ile, irritab le, 
scared, afraid, ashamed, guilty, nervous, and jitter y. High PA is characterized by 
exci tement and high energy, whereas low PA is characterized by lethargy and sadness. 
General negative mood states (e.g., anger, fear, guilt) reflect high NA, whereas 
tranquility and calmness are associated with low NA. Validity and reliability have been 
well established. Internal consistency for PA ranges from .86 to .90, and from .84 to .87 
for NA, depending upon the time instruction utilized (i.e., right now, today, during the 
past few days, during the past week, during the past year, in general or on average). 
Convergent validity was high, such that the convergent correlations ranged from .89 to 
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.95. Discriminant correlations were low (-0.02 to -0.18). External validity has also been 
supported through significant correlations with other measures of psychological distress 
(Beck Depression Inventory: PA = -.35, NA = .56; State-Trait Anxiety Inventory State 
Anxiety Scale: PA= -.35, NA= .51). Additionally, the correlation between the two 
PANAS subscales is low, indicating PA and NA share 1-5% of their variance (Watson 
et al., 1988). This is a strong indication of the scales' relative independence. 
Furthermo re, Watson and colleagues reported mean PA to range from 29. 1 to 36.2 and 
A to range from 14.8 to 22. 1 depending upon the time period assessed ( e.g ., today, 
past few days, past year) . Participants in the present study were instructed to answer 
questions on the PANAS according to how they had been feeling over the past few 
days. The reliabilit y coefficient alpha of PA and NA of the present data are .87 and .89. 
respectivel y. 
Si ckness !111pact Pro.file (SIP) 
The STP is a measure of sickness-related dysfunction and was develop ed for use 
with individuals with acute and chronic illnesses (Bergner et al., 1976). The full version 
of the SIP consists of 12 subsca les that address behaviors such as participation in socia l 
activities and ability to comp lete activities of daily living. Research on women 
receiving radiation therapy for breast cancer has demonstrated the subscales of home 
management, mobility , recreation and pastimes, and work are the most relevant to 
functional outcomes for this population (Graydon, 1988, 1994 ). In order to decrease the 
burden of completing such a lengthy measure, only these four subscales were 
administered to participants. Previous research has indicated that selecting specific 
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subscales pertinent to disruption in functionin g related to a particular clinical situation 
or to gender does not compromise vital data. Furthermore, the subscales themselves 
retain adequate psychometrics (Graydon , l 994; Johnson, 1996; Jolmson , Nail, Lauver, 
King , & Keys, 1988; ail, l 993; Nail, King, & Johnson , 1986). Participants in the 
present study were also specificall y instruct ed to respond to items in tem1s of changes 
due to having breast cancer and enduring breast cancer treatment, in order to avoid 
confounding effec ts of changes related to other illnesses , seasonal changes in activities, 
or life events. 
It has been demonstrated that the SIP has high test-retest reliability (.92) and 
internal consistency (.94). Additiona lly, validity has been demonstrated through 
correlations with self-reported dysfunction (.69) and illness (.63 ; Bergner, Bobbitt , 
Carter, & Gilson, 1981 ). Prior to rescoring, reliability coeffic ient alphas for subsca les 
used in the present study were .72 for home management, .73 for mobility , .70 for 
recreation and pastimes, and .42 for work. The work subscale does not account for 
individuals who arc not working because of nonhealth-related factors , like being retired 
or unemplo yed (from a lay off) , and, therefo re, does not provid e an accurate assessment 
of impairment in this area (Pollard & Johnston, 200 l ). Furthermore , due to the low 
reliability of the work subscale, it was excluded from analyses . 
Research ers have reported problems with the original method used to score the 
SIP (McDowell & N ewe II, 1987; Pollard & Johnston, 2001; Post, de Bruin, de Witte, & 
Schrijvers , 1996). The original scoring procedure produced an individual score for each 
subscale or area of functioning , as well as a total score representative of general 
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functioning. Each item in the various subscales was weighted to reflect the degree of 
dysfunction that item represented. In order to obtain a percentage limitation score for a 
particular subscale, the weighted score for each item endorsed was summed , divided by 
· the maximum possible score for that subscale, and then multiplied by I 00. The problem 
with this scoring procedure is related to the summin g of endorsed weighted items. An 
individual who is functionally more impair ed than another , may appear to exhibit less 
dysfunction due to endorsing fewer items. For example , if someone endorsed, "I am not 
doing any of my usual physical recreation activities," it would imply that they would 
logically not endorse other items within that subscale such as, "I do my hobbies and 
recreation for shorter periods of time." Howeve r, using the original scoring procedure, 
the more items the respondent endorses the higher the limitation score. Therefore, i r 
someone were to endorse the item representative of the highest limitation (e.g., I am not 
doing any of my usual physical recreation or activities), it would preclude them from 
endorsing other items and result in receiving a misleading score reflective of a lower 
level of limitation than they actually experience. Pollard and Jolmston proposed a new 
scoring method that produce s a limitation score that more accuratel y reflects the 
individual ' s true level of functioning. They proposed using the item endorsed by the 
respondent with the maximum weight. For example , if a respondent endorsed three 
items, the item with the highest weight would be used to calculate the percent limitation 
score.-The percent limitation score is then calculated by dividing the maximum item 
weighting endorsed by the maximum item weighting in that subscale and multiplying 
by 100 (see Figure 2). After rescoring , similar reliability coefficient alphas for the three 
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max item weighting endorsed 
100 • 
max item weighting in subscale 
Figure 2. Percent limitation score graph depicts the percent limitation score formula for 
subscale scoring on the SIP. 
subscales were obtained with .74 for home management , .7 1 for mobility , and .68 for 
recreation and pastimes. 
Impact of Events Scale-Revised (!ES) 
The IES consists of 15-items that are answered on a 4-point Likert sca le (from 
0 = not at ail, to 3 = often). ft was designed to assess avoidant and intru s ive thoughts 
and emotions (Horowit z, Wilner , & Alvare z, 1979) that are similar to avo idant and 
intru sive symptoms characteristic of PTSD (Ame rican Psychiatric Association , 2000). 
The JES is compr ised of two subsca les that assess intru sive thoughts and fee lings 
(intrusive subscale) and avoidance of particular thoughts, feelings, and situations 
(avoidance subsca ie). Avoidance and intrusion sym ptoms are of particular interest to the 
current project, as research has demonstrat ed many breast cancer survivors exper ience 
such distressirrg symptoms (Cordova et al., 1995). For purposes of this study, 
participants were asked to complete the IES in relation to having breast cancer. The IES 
determines the frequency participants have experienced a situation related to breast 
cancer (i.e., "I tried not to talk about it," "Any reminder brought back feelings about it") 
(Zilberg, Weiss, & Horowitz , 1982) and produces separate scores for the intrusion and 
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avoidance subscales, as wel l as a total stress score. Clinical interpretation of total stress 
sco res is as follows: 0-8, subclinica l range ; 9-25, mild range; 26-43, moderate range; 
44-75, severe range (Marren & Christianson, 2004) . Furthermore, a score greater than 
or equal to 20 on either subsca le is indicative of a high , clinical ly meaningful score 
(Horow itz, 1982). 
The IES has established test-retest reliability for the total assessment score (.87), 
the intrusion subscale (.89), and the avoidance subscale (.79; Horowit z et al., 1979). 
Reliabilit y coefficient alphas for the present project were .84 for the avo idance subscale, 
.89 for the intrusion subscale, and .91 for the complete measure . 
Perception of Disclosur e (DJS) 
The ors was a s ing le- item measure used to assess participants' history otpr ior 
disclosure. Patiicipants' perception of the ex tent to which they had alrea dy expressed 
their deepest thoughts and feelings about their cancer exper ience throu gh w riting or 
discussion with others was assessed . Patiicipants rated the ex tent of prior disc losure on 
a sca le ranging from O (not at all) to 10 (complete disclosure). 
This measure is sim ilar to those used in previous expressive writing research 
(Greenberg & Stone, 1992; Pennebaker & Beall, 1986 ; Pennebaker et al., 1988). 
However, research is mixed with regard to the impact of prior disclosure on one's 
ability to benefit from an expressive writing intervention. For example, researchers 
found that up to 75% of participants wrote about thoughts and feelings related to a 
traumatic event that they had not previously disclosed to anyone. These particular 
participants went on to experience a decrease in health problems (Pennebaker & Beall). 
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Greenbe rg and Sto ne randomly ass igned par tic ipant s to either write about a prev iou sly 
discussed traumatic eve nt or a traumatic eve nt that th ey had "kept to th ems elves. " They 
found no differences in outco me between indi v idu a ls who wrote about a pr ev iousl y 
undisclosed traumatic event ve rsus those who wrote abo ut a traumatic eve nt they had 
pr ev iously discussed w ith others . Further researc h is necessary to determine the impa ct 
of prior disclosur e on the benefits one may exper ience as a res ult of exp ressive writing. 
Linguistic Jnqw, T and Word Count 
(UIVC) 
The LIWC was used to anal yze the linguistic content of express ive wr itin g 
narratives. The LlWC was developed by Francis and Pennebaker ( 1993) and was 
recently updated (Pennebaker et al. , 2003). The UW C was deve loped to ana lyze 
emotional , cogn itive, structural, and proce ss e lements of wr itt en and verba l speec h, 
parti cularly of individuals who hav e exper ienced a traumatic or distressing eve nt. The 
most recent vers ion of the L!WC co nta ins a defau lt dictionary made up of2,300 wo rds 
and word stems. The d ictionary words are organ ize d int o wo rd ca tegories, including 17 
sta nd ard lin guistic dimensions (e.g ., word count, percentage of pronouns, numbers) , 25 
categories related to ps yc ho logica l co nstru cts (e .g., PA, NA, cognition) , 19 categories 
related to persona l co ncerns (e.g., wo rk, leis ure act iv iti es), andlO catego ries pertaining 
to re lat ivi ty (i.e., time, space, motion). Each word represents applicable word 
categories. For example, the word "c ried" is contained in four different linguistic 
categories, including sadness, overall affect , negative emotion, and past tense verb. The 
LIWC searches tex t files and calculates the percentage of words in the text that reflect 
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various linguistic dimensions (e.g., soc ial processes, time, metaphysica l issues, leisure 
activity) as found in the comprehensive LIWC dictionary. The LIWC has adequate 
validity demonstrated through positive correlations with independent jud ges' content 
ratings (negative emotionality = .69; positive emotionality = .64). 
The cunent project examined words reflecting positi ve emotion s (e.g., happy, 
good, jo y), negativ e emotions (e.g., hate , worthless, scared), cognitive processes (e.g., 
know, because , consider), and verb tense (e.g. , walk, walked, will). The rationale for 
examining these particular word categories is based on previous research. First, trauma 
and disclosure theor ies indicate that the expression of one's thoughts and emotions 
related to a distre ssing e\'cnt is necessary to process or make sense of the experie nce 
(Nemeroff et al., 2006). Research has demonstrated that individuals who were 
instructed to express their deepest feelings about a distressing event evidenced health 
benefits, whereas those who merely wrote about the facts of an event did not (Esterling 
ct al., 1990). Other researc hers found that individuals who wrote about the facts as well 
as their feelings related to a traumatic event evidenced significant improveme nts in 
health problem s relative to individuals who just wrote about the facts of a trauma. 
Furthermore , participants who wrote about facts and emotions experienced long-tem1 
improvements in health , whereas those who just wrote about their emotions did not 
(Pennebaker & Beall , 1986). Based on this research and the previously summarized 
research on the resultant linguistic patterns of expressive writing interventions, 
emotion-related words and cognitive process words were examined. Specifically , PA 
and NA words were examined, as opposed to general affective processes , as this is the 
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most comprehensive and descriptive way to examine emotional expression with the 
LIWC. Lastly , researchers have found a relationship between the use of past tense verbs 
and distress, indicating that the use of fewer past tense verbs is related to greater distress 
(Pennebaker et al., 1997). Therefore , the cuITent project also examined verb tense. 
Procedur e 
Two weeks prior to radiation therapy completion, participants were recruited 
during their routine medical appo intment. They were asked to comp lete a Participant 
Screening Form in order to detem1ine whether they met inclusion criteria for the study. 
One week prior to complet ion of treatment , participants who met inclusion criteria were 
interviewed to obtain baseline data (demograp hic var iables, TES, S[P, PANAS. DIS). 
Participants were then randomized to one of the three treatment groups. At participants ' 
final radiation therapy appointments , they were provid ed with instructions for 
participating in the study. Pa1iicipants in the EW intervention were instructed to write 
about their "ve ry deepest thoughts and feelings about [their] cancer and cancer 
treatment. " They were asked to write for 30 minut es on 3 consecutive days over a 5-day 
time period. Participants in the GHI control group were provided with general 
infom1ation about where to find resourc es related to cancer and cancer treatment. The 
JES, SIP, PANAS, and DIS were again completed by participants at 1 week, 4 weeks, 6 
months, and 1 year postradiation treatment. This follow-up interval was chosen in order 
ascertain both short-tenn and long-te1m effects of the intervention. 
CHAPTER IV 
RESULTS 
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This section provides results of data analyses organized by research questions 
presented in Chapter II. Preliminary analyses were first conducted to obtain descriptive 
information ( e.g., age, ethnicity, education, marital status, stage of disease, history of 
prior treatment) for the participants. The preliminary analyses are followed by results of 
statistical calculations guided by the research questions. 
Analyses were conducted on an intent-to-treat basis. The principle of intention-
to-treat as applied to statistical analyses and in relation to the current project, refers to 
the practice of including all participants in all analyses regardless of whether they were 
compliant with the treatment they were randomized to receive ( e.g., as in clinical trials; 
May, DeMets, Friedman, Furberg, & Passamani, 1981). Research has demonstrated 
that, by excluding participants who did not adhere to the treatment protocol, results can 
be easily biased. Treatment compliance is reasoned to be in and of itself a measure of 
outcome. Therefore, if analyses are adjusted for treatment compliance (i.e., excluding 
participants who were not compliant with the intervention), it results in one outcome 
being adjusted for another outcome that may lead to confounding results (DeMets, 
2004), inaccuracies, and difficulty in interpreting findings (Friedman , Furberg, & 
DeMets, 1996). Therefore, all data collected from participants within the current project 
were examined irrespective of treatment compliance in order to preserve internal 
validity and avoid biasing treatment comparisons (Schulz & Grimes, 2002). 
The intention-to-treat principle presented as an issue within the current project 
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when it was discovered that all of the expressive writing group participants did not write 
as instructed. Specifically, of the 89 participants who were randomized to the expressive 
writing intervention, 67 wrote three times as instructed, two wrote two times, and two 
wrote only one time. Eighteen people who were randomized to the treatment group did 
not write at all. Reasons for not writing included overtly refusing to write, merely not 
completing any of the writing sessions, leaving radiation treatment early (prior to the 
patient's last radiation appointment when the treatment protocol was dispensed), and 
unknown reasons. Other participants who did not write indicated that they had mailed 
their expressive writing narratives; however, the researchers never received them (Table 
3). 
Preliminary Analyses 
Prior to addressing the research questions for the present study, descriptive 
analyses were conducted on baseline measures of age, ethnicity, marital status, 
Table 3 
Reasons for Not Writing 
Frequency 
(N = 18) 
Reason n % 
Refused 3 17 
Did not comp lete 6 33 
Left radiation treatment early 6 
No information 4 22 
Lost in the mail 4 22 
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education, employment, religion, stage of disease, and history of prior psychiatric 
treatment. The questionnaire utilized provided a list of five to eight specific options to 
check for each demographic question. Therefore, in order to better summarize the 
information provided, the data were collapsed to form conceptually meaningful groups 
for marital status, education, and employment (Table 4). 
Data were further analyzed for significant demographic differences between the 
expressive writing treatment group and the general health information control group 
utilizing t tests and chi-squared analyses. No statistically significant differences 
between groups were found (Table 5). In addition, data were analyzed for differences 
Table 4 
Summary of Collapsed Demographic Groups 
Category Participant response options Collapsed groups 
Marital stan1s Single (never manied) 1. Single: never manied 
Separated or Divorced separated 
Widow divorced 
Married 
Cohabitating 2. Manied : married 
cohabitating 
Education gt" grade or less 1. Less than high school graduate: 81" grade or less 
Some high school some high school 
High school graduate /GED 
Technical school graduate 2. High school graduate , some 
Some college college, and technical school 
Master's degree graduate 
Doctorate degree 
3. College graduate and above: college graduate 
master's degree 
doctorate degree 
Employment Full-time ( ~30 hours/week) 1. Employed: full-time 
status Part-time part-time 
Homemaker 2. Unemployed: unemp loyed 
Unemp loyed homemaker 
Retired retired 
Disabled disabled 
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Table 5 
Test of Statistical Differences Between Treatment and Control 
Chi Square /! Cramer's V/SMDa 
Variable value p-value value 
Ethnicity 7.67 0.18 0.21 
Marital status 0.82 0.37 0.07 
Education 1.67 0.43 0.10 
Employment status 2.01 0.16 0.11 
Religiosity 8.81 0.12 0.22 
Breast cancer stage 0.10 0.95 0.02 
Therapy since CA diagnosis 0.37 0.55 0.05 
Focus of therapy 0.01 0.93 0.01 
Age -0.56 0.57 0.09" 
Number of therapy sess ions 0.05 0.96 0.01 a 
3 SMD = standardized mean difference as related tot test. 
across demographic variables and baseline outcome variables for participants from the 
data collection site in California versus those from the data collection site in Utah. No 
significant differences were found with the exception of history of therapy since one's 
cancer diagnosis (t = 3.00; p = 0.00). Specifically, of the 45 participants who reported 
seeing a therapist since their breast cancer diagnosis, 20 were from the site in 
California. This is noteworthy as 40.8% (N = 20) of participants from California had 
previously seen a therapist, whereas only 19.2% of participants from Utah had seen a 
therapist. 
The final sample for the present study consisted of 180 participants ( expressive 
writing group= 89; general health information group= 91). Participant characteristics 
are presented in Table 6. The majority were Caucasian (N= 145; 80.6%) and were 
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Table 6 
Summary of Participant Characteristics 
Treatment group Control group 
(N = 89) (N = 91) 
Variable 11 % n % 
Age 
21-34 2 2.0 8 8.1 
35-44 16 17.7 11 12.2 
45-54 26 29.0 31 34.1 
55-64 20 22.4 21 23.1 
65 and Above 25 28.7 20 22.0 
Ethnicity 
Caucasian 78 87.6 67 73.6 
Hispanic 6 6.7 12 13.2 
Asian 3 3.4 5 5.5 
African American 0 0 1 1.1 
Native American 0 0 3 3.3 
Other 0 0 1.1 
Marita l Status 
Single 26 29.2 32 35.2 
M arried/coha bi ta ting 63 70.8 58 63.7 
Education 
Less than HS grad 7 7.9 4 4.4 
HS grad, some college, 
Tech school 53 59.6 61 67.0 
College grad and above 29 32.6 25 27.5 
Emp loyment status 
Emp loyed 41 46.1 52 57.1 
Unemp loyed 46 51.7 38 41.8 
Religiosity 
Religious 
LDS 33 37. 1 33 36.3 
Protestant 32 36.0 19 20.9 
Catholic 12 13.5 22 24.2 
Jewish 0 0.0 2 2.2 
Other 3 3.4 5 5.5 
Not religious 9 10.1 8 8.8 
(table continues) 
Treatment group Control group 
(N= 89) (N = 91) 
Variable n % n % 
Breast cancer stage 
Stage I 37 41.6 37 40.7 
Stage II 43 48.3 45 49.5 
Stage III 9 10.1 9 9.9 
Prior disclosure 
0-3 (little) 17 19.1 13 14.4 
4-7 (moderate) 24 26.9 29 32 .3 
8-10 (high) 48 54.0 48 53.3 
Note. Percentages based on the number of participants who responded to 
each individual question . The number of respondents for each question 
ranged from 87 to 89 for the treatment group and from 89 to 90 for the 
control group. 
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diagnosed with either stage I (N = 74; 41.1 %) or stage II (N = 88; 48.9%) breast cancer. 
Participants ranged in age from 24 to 89 (mean= 54.81; SD= 12.64) . Many participants 
were man-ied or cohabitating (N = 121; 67.2%) and noted affiliation with a particular 
religion (N = 178; 89.5%). Approximately half of participants were employed (N = 93; 
51.6%). Few participants noted seeing a therapist since their breast cancer diagnosis 
(N = 45; 25%; see Table 7). The vast majority of those who had participated in therapy, 
did so for fewer than five sessions (N = 37; 82.2%) and most utilized therapy to focus 
on their cancer experience (N= 34; 75.6%). Furthermore, the majority of participants 
(N = 96; 53.6%) indicated having engaged in a high degree of disclosure related to their 
breast cancer experience prior to entering the study, while few reported having 
disclosed relatively little (N = 30; 16.8%). 
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Table 7 
Therapeutic History 
Treatment group Control group 
(N= 89) (N = 91) 
Variable n % n % 
Therapy since CA diagnosis 
Yes 24 27.0 21 23 .1 
No 64 71.9 69 75.8 
Focus of therapy 
Cancer related 18 75.0 16 76.2 
Other issues 6 25.0 5 23.8 
Number of therapy sessions 
1 session 11 45 .8 9 42.9 
2-5 sess ions 10 41.7 7 33.3 
;;;:6 sess ions 3 12.5 3 14.3 
Research Questions 
Eff ect of Treatment 
The first research question sought to determine whether an expressive writing 
intervention had an impact on outcomes (PANAS: PA and NA; SIP: general 
functioning; RIES : intrusion and avoidance symptoms), by specifically examining 
changes in the EW treatment group outcome scores from baseline to each follow-up 
point (1 week, 4 weeks, 6 months, 1 year) as compared to the GHI group scores. It was 
originally proposed to answer this research question by conducting mixed factorial 
ANOV As with one between subjects factor (treatment vs. control) and one within 
subjects factor (time interval). However, after further exploration, it was determined 
that linear mixed models would provide more accurate analyses of the data. This 
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decision was based on three main factors. First, linear mixed models accommodate for 
missing data, which is common when data is collected longitudinally (Fitzmaurice, 
Lairds, & Ware, 2004), as in the present study. The current study contains missing data 
for several reasons, including participants refusing to participate or to complete a 
measure, incomplete measures, and losing measures in the mailing process. Linear 
mixed models are able to accommodate for missing data by simultaneously modeling 
for fixed effects (mean response or population characteristics shared by all participants) 
and random effects ( effects unique to each individual participant; Fitzmaurice et al.). By 
allowing for random variation across individuals, and thus multiple missing data points, 
each individual's data are retained (Edwards, 2000). This not only provides a more 
accurate picture of outcome, but also serves to maintain the integrity of the sample size, 
which can impact power and statistical significance (Cohen, 1988) . Mixed factorial 
ANOY As on the other hand, cannot accommodate for missing data, and in fact omit 
participants if they have missing data. This can lead to sampling bias , as the analyses 
are conducted solely on participants without missing data (Gueorguiva & Krystal, 
2004) . Second, linear mixed models assume data to be dynamic; that is, longitudinal 
data need not change in a linear pattern over time. Outcome data are not assumed to 
change linearly, as in ANOV As, but are allowed to change in a nonlinear or curvilinear 
manner. Lastly, it is common for an individual's outcome data to be correlated at each 
follow-up point in a longitudinal design. In fact, the present study yielded correlations, 
ranging from .20 (p = 0.02) to .76 (p = 0.00), between data points for the three outcome 
measures (PANAS, SIP, IES). If correlations between individuals' repeated outcome 
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scores are not considered, parameter estimations can be deflated, hypothesis tests are 
likely to have increased Type I error, and statistical power may be decreased. To avoid 
such bias, linear mixed models utilize the correlations or covariance between repeated 
individual observations when modeling data (Edwards). Conversely, mixed factorial 
ANOV As assume that the values of outcome observations are independent, which can 
lead to such biases (Edwards) and nonnormality (Ferrell, 2005). 
Prior to fitting the linear mixed models, general exploratory analyses were 
conducted examining the relationship between group (EW and GHI) and outcomes 
(PANAS, SIP, IES). Then, the relationship between each covariate of interest and 
outcome was examined. The covariates of interest were age, breast cancer stage, 
previous therapy, marital status, education , and prior disclosure. The decision to include 
these particular covariates within the models was based upon findings of previous 
research, results of exploratory analyses, and the nature of the intervention. Previous 
research has indicated that younger individuals with breast cancer (typically under age 
55) tend to respond to their cancer diagnosis with greater distress (Palmer et al., 2004), 
increased symptoms of depression and anxiety (Kissane et al., 2004; Pinder et al., 1994; 
Tibbs, 2003), and increased intrusion symptoms as compared to older individuals 
(Tjemsland et al., 1996a , 1996b). Concerning cancer stage, more advanced stage cancer 
is associated with increased incidence of PTSD (Jacobsen et al., 1998) and lower PA 
(Voogt et al., 2005). Being married has also been associated with intrusive 
symptomatology (Tjemsland et al., 1996a, l 996b ). In addition, it is hypothesized that a 
history of participating in therapy (i.e., opportunity to express thoughts and emotions) 
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may be related to outcome given that these individuals may have already had not be 
assumed that just because one participated in therapy that she necessarily engaged in 
meaningful disclosure. It also cannot be assumed that if one did not participate in 
therapy, she has not disclosed her thoughts and feelings . Therefore, a measure of 
perception of prior disclosure was also included as a covariate. Furthermore, provided 
that the intervention in the present study involved expressing oneself through the act of 
writing, it was hypothesized that education level may impact outcome . Lastly, results of 
exploratory analyses revealed significant relationships between the aforementioned 
covariates and various outcomes. 
The structure of final models included one independent variable (intervention), 
one dependent variable (outcome), and seven covariates (time, age, stage , previous 
therapy, marital status, education, prior disclosure). Fixed effects (between-subjects 
factor) within each model included group means for EW and GHI, and random effects 
(within-subjects factor) included individual participant variables and the intercept. A 
residual term was also included in the models, which allowed for random intercepts, 
controlling for potential baseline differences. Interaction effects were originally 
included in all final modeling. However, no significant interactions between group and 
time were found for any model. In order to free up variance potentially accounted for by 
the interaction terms, the interaction terms were removed from the models and the 
models were rerun. In addition, due to the relatively few prior studies conducted on the 
effects of expressive writing on breast cancer patients, and thus the exploratory nature 
of the present study, hypotheses regarding which covariates would be most important to 
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examine were not possible. Therefore, the final models presented are full models, which 
retain all covariates irrespective of statistical significance. 
PANAS Exploratory analyses were first conducted on PA (Figure 3). Both the 
EW and GHI groups evidenced an increase in PA from baseline (EW: mean= 34.02, 
SD= 7.30; GHI: mean= 33.11, SD= 7.80) to the 1-year follow-up (EW: mean= 38.09, 
SD= 8.84; GHI: mean= 34.75, SD= 9.43). However, the EW group appears to have 
made larger gains in PA at 1 year postradiation treatment as compared to the GHI group 
(Table 8). Interestingly, the EW group's PA scores did not steadily increase from 
baseline, but increased at 1 week by .90 of a point, decreased at 4 weeks by .69 of a 
point, and then increased from that point forward. The GHI group had a slightly 
different trajectory , with a decrease in PA at 1 week by 1.81 points and then increased 
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Figure 3. PANAS: Mean PA scores. Graph depicts overall mean PA scores for 
treatment versus control groups from baseline through 1 year posttreatment. 
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Table 8 
PANAS: Mean PA Outcome Scores for EWand GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
PANAS: PA 
EW 34.02 7.30 34 .92 7.62 34.23 8.04 36.26 7.61 38.09 8.84 
GHI 33.1 1 7.80 31.30 8.65 32.23 8.43 32.85 8.75 34.75 9.43 
from that point forward. Furthermore, baseline PA scores for both groups were similar 
to scores of individuals in the general population (33.3), when asked about their affect 
over the past few days (Watson et al., 1988b) as in the present study. 
With regard to the relationship between PA and the covariates, Pearson R 
correlations revealed few significant relationships (Table 9). Specifically, a small 
negative relationship was found between PA and cancer stage at baseline (r = -.20, 
p = 0.01), indicating that higher PA is associated with lower cancer stage. PA was also 
positively associated with previous therapy at 4 weeks (r = .15, p = 0.05) and education 
at 6 months (r = .18, p = 0.02). 
After exploratory analyses were performed a linear mixed model was fitted with 
the seven predictor variables of time, age, stage, previous therapy, marital status , 
education, and prior disclosure , and one dependent variable of PA. Fixed effects 
(between-subjects factor) within the model included PA group means for EW and GHI. 
Random effects (within -subj ects factor) included individual participant variables and 
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Table 9 
Correlations Between PA Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
PANAS: PA 
Baseline .09 (0.29) -.20 (0.01 )* .12(0 .11) -.04 (0.61) .07 (0.35) .18 (0.02)* 
1 week .03 (0.73) -.13 (0.10) .06 (0.45) .04 (0.59) .09 (0.26) .19 (0.01)* 
4 weeks .03 (0.72) -.09 (0.24) .15 (0.05)* -.03 (0.66) .01 (0.92) .17 (0.02)* 
6 months -.07 (0.40) -.14 (0.08) .06 (0.44) .15 (0.06) .18 (0.02)* .17 (0.03)* 
I year .07 (0.44) -.IO (0.27) .01 (0.88) .09(0.31) .12 (0.17) .08 (0.32) 
* p-value :-=;0.05. 
the intercept. A residual term was also included in the model, which allowed for random 
intercepts. As shown in Table 10, results yielded a significant intervention effect for 
PA . This indicated that the EW group evidenced a significantly larger increase in PA 
over time as compared to the GHI group, but the GHI group significantly improved 
over time as well. Cancer stage was demonstrated to have a significant impact on 
outcome , such that individuals with a more advanced stage breast cancer tended to have 
lower PA. Please note that participants within the study had stage I, II, or III breast 
cancer. Therefore, "more advanced stage cancer" is in reference to participants of this 
study, as opposed to individuals with stage IV (advanced stage) cancer. Previous 
disclosure was also significantly related to PA, indicating the greater degree of prior 
disclosure the higher the reported PA. 
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Table 10 
Linear Mixed Model: PA 
95% Confidence 
interval 
Regression 
Variable coefficient SE p-value Lower Upper 
Intercept 28.30 4.31 6.58 0.00* 19.8 1 36.80 
Intervention 2.57 0.94 2.72 0.01 * 0.71 4.43 
Time 0.04 0.01 3.04 0.00* 0.01 0.07 
Age -0.02 0.04 -0.41 0.69 -0.09 0.06 
Cancer stage -1.63 0.76 -2.15 0.03* -3.13 -0.13 
Therapy 2.10 1.15 1.82 0.07 -0.17 4.36 
Marital status -0.11 1.01 -0.11 0.91 -2.10 1.88 
Education 0.91 0.88 1.03 0.30 -0.83 2.64 
Prior disclosure 0.46 0.16 2.92 0.00* 0.15 0.77 
* p-va lue ::::;0.05.p 
Variance and covariance estimates for the random parameters of the model were 
also examined and are presented in Table 11. Analyses revealed that the intercept varied 
significantly across individuals (UN; 1, 1), but there was not an interaction between the 
intercept and linear slope across participants (UN; 2,1). However, the linear slope 
varied significantly across individuals (UN; 2,2). 
Exploratory analyses on the trajectory of NA across the year of follow-up 
indicated a slow decline in scores (Figure 4). Although the treatment group evidenced a 
mean NA score that was 1.71 points lower than the GHI group at baseline, this 
difference was not found to be statistically significant (t = 1.55, p = 0.12). From 
baseline to 1 week (first postintervention assessment) NA scores decreased by 1.41 
points for the EW treatment group and by 1.85 points for the GHI group (Table 12). 
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Table 11 
Estimates of Covariance Parameters: PA 
Parameter Estimat e SE 
Residual 27.56 1.79 
UN (1,1) 32.63 4.64 
UN (2,1) -0.06 0.09 
UN (2,2) 0.01 0.00 
* p-value ~ 0.05 . 
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Figure 4. PANAS: Mean NA scores. Graph depicts overall mean NA scores for 
treatment versus control groups from baseline through 1-year posttreatment. 
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Table 12 
PANAS: Mean NA Outcome Scores for EW and GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
PANAS:NA 
EW 17.81 6.95 16.41 6.84 16.48 6.75 16.77 7.54 14.31 5.36 
GHI 19.52 7.78 17.67 7.48 17 .11 7.50 16.72 6.82 16.0 1 5.93 
Scores for the EW and GHI groups then diverged in their trajectories. The EW 
treatment group evidenced a slight increase in NA from 1 week to 6 months and then a 
sharp decrease from 6 months to 1 year. Conversely, the GHI group evidenced a slight 
but steady decline in scores from 1 week to the 1 year follow-up assessment. 
Furthermore, baseline NA scores for both groups were similar to scores of individuals 
in the general population (17.4), when asked about their affect over the past few days 
(Watson et al., 1988b) as in the present study. 
Preliminary analyses of the relationship between NA scores and covariates 
revealed few and inconsistent relationships (Table 13). Specifically, age was associated 
with NA at baseline and 1 week, suggesting that younger individuals experienced 
greater NA. Breast cancer stage was found to have a positive relationship with NA at 
baseline and 1-week postradiation treatment, indicating that as breast cancer stage goes 
up, NA scores also tend to increase. Furthermore , previous therapy was negatively 
related to NA at baseline (but at no other time point), suggesting that participants who 
had higher levels of NA did not have a history of previous therapy. Marital status was 
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Table 13 
Correlations Between Baseline NA Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
PANAS : NA 
Baseline -.21 (0.01)* .18 (0.02)* -.17 (0.02)* .04 (0.64) -.03 (0.74) -.13 (0.08) 
1 week -.17 (0.03)* .25 (0.00)* -.11(0.18) .02 (0.80) -.08 (0.32) -.05 (0.56) 
4 weeks -.10 (0.21) .09 (0.22) -.04 (0.62) -.07 (0.37) -.00 (0.95) -.06 (0.46) 
6 months -.07 (0.37) .11 (0.15) -.04 (0.66) -.07 (0.40) -.04 (0.65) -.07 (0.35) 
1 year -.12 (0.15) .15 (0.10) -.03 (0.71) -.25 (0.00)* -.14(0 .10) -.12 (0.18) 
* p-value :::::: 0.05. 
also related to NA, indicating that participants who were single tended to experience 
increased NA at I-year posttreatment. 
After exploratory analyses were perfo1med, a linear mixed model was fitted with 
identical predictor and dependent variables used for the PA model. Results revealed no 
significant intervention effect (Table 14). However , all participants evidenced 
significant improvements in NA over time. Furthermore, more advanced breast cancer 
was associated with higher levels of NA. 
JES. Exploratory analyses were conducted on intrusion and avoidance symptoms 
(IES) . With regard to intrusion symptoms , general trends indicated a slight decrease in 
symptoms from baseline through the 4-week follow-up period (Figure 5). Then, the EW 
group evidenced an increase in intrusion symptoms at 6 months (M= 10.52; SD = 9.15) 
and a sharp decrease at 1 year (M = 7.53; SD= 7.24). Conversely, the GHI group 
reported a slight decrease in symptoms from baseline to the 6-month follow-up, with a 
sharper decline at I-year postradiation treatment (Table 15). With regard to participant's 
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Table 14 
Linear Mixed Model: NA 
Regression 
Variable coefficient SE 
Intercept 23.82 3.76 6.33 
Intervention -0 .79 0.82 -0.96 
Time -0.03 0.01 -3 .18 
Age -0 .06 0.03 -1.67 
Cancer stage 1.55 0.67 2.33 
Therapy -0.55 I.OJ -0 .55 
Marital status -1.03 0.88 -1.17 
Education -0 .87 0.77 -1.13 
Prior disclosure -0.16 0.14 -1.15 
* p-valu e ~ 0.05. 
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Figure 5. IES: Mean intrusion scores. Graph depicts overall mean intrusion scores for 
treatment versus control groups from baseline through 1-year posttreatment. 
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Table 15 
!ES: Mean Intrusion Outcome Scores for EW and GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
IES: Intrusion 
EW 10.76 8.80 10.57 8.36 9.71 8.54 10.52 9.15 7.53 7.24 
GHI 10.27 9.47 9.69 8.71 9.26 9.14 9.07 8.67 7.39 6.88 
average total stress scores ( sum of intrusion and avoidance scores), both the EW and 
GHI groups reported symptoms in the mild range from baseline (M = 21.69; 
SD= 16.90) through 1 year (M= 15.36; SD= 14.31) postradiation treatment. 
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Research has indicated that obtaining a score ~ 20, on either the intrusion or 
avoidance subscale, is indicative of significant stress that necessitates further 
assessment and potential intervention (Horowitz, 1982). Therefore, intrusion scores 
were examined with regard to the frequency with which the clinical cutoff score ( ~ 20) 
was obtained (Table 16). Due to having similar scores, this was examined for both the 
EW and GHI groups combined. Approximately 14% of individuals obtained a high 
score (at or above 20) on the intrusion subscale from baseline through the 4-week 
follow-up point. Scores at 1-year postradiation treatment indicated an almost 50% 
decrease in the number of participants scoring at or above this clinical cutoff. 
Exploratory analyses were also conducted on the relationship between intrusion 
symptoms and covariates (Table 17). The most consistent significant relationships were 
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Table 16 
Intrusion Subscale: Frequency of Scoring 2:: 20 (clinical cutojj) 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
IES N % N % N % N % N % 
Intrusion 12 14.J 12 14.1 12 14.1 13 16.0 6 8.2 
Note . Percentages are based on the number of individuals who responded to the IES questionnaire at 
each time point. 
Table 17 
Correlations Between Intrusion Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
IES: Intrusion 
Baseline -.21 (0.01)* .13 (0.09) -.13 (0.09) .04 (0.61) .07 (0.37) -.10 (0.17) 
I week -.29 (0.00)* .21 (0.01)* -.15 (0.05)* .04 (0.60) .0 I (0.96) -.07 (0.40) 
4 weeks -.29 (0.00)* .16 (0.03)* -.11 (0.16) -.03 (0.68) -.00 (0.99) -.04 (0.60) 
6 months -.28 (0.00)* .16 (0.05)* -.07 (0.41) -.04 (0.61) .05 (0.50) -.08 (0.33) 
I year -.33 (0.00)* .08 (0.34) -.08 (0.34) -.05 (0.54) .05 (0.58) -.10 (0.25) 
* p-value ~ 0.05. 
found between intrusion symptoms and age (significant at all time points except 1 week 
postradiation treatment) and intrusion symptoms and cancer stage (significant at 1 
week, 4 weeks, and 6 months). These findings indicated that younger individuals tend to 
experience more intrusion symptoms than their older counterparts and individuals with 
more advanced cancer also experienced more intrusion symptoms than individuals with 
less advanced breast cancer. In addition, previous therapy was found to be related to 
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intrusion symptoms at I-week postradiation treatment, indicating that individuals with 
no history of previous therapy experienced greater intrusion symptoms. 
After exploratory analyses were performed, a linear mixed model was fitted with 
the seven predictor variables of time, age, stage, previous therapy, marital status, 
education, and prior disclosure, and one dependent variable of intrusion. Fixed effects 
(between-subjects factor) within the model included intrusion group means for EW and 
GHI. Random effects (within-subjects factor) included individual participant variables 
and the intercept. A residual term was also included in the model, which allowed for 
random intercepts , controlling for potential baseline differences. As shown in Table 18, 
results indicated no intervention effect (regression coefficient= 0.81; p = 0.42). A 
significant time effect was found (regression coefficient = -0.03; p = 0.00) indicating 
participants tended to experience a decrease in intrusion symptoms over time. Lastly , 
there was a significant relationship between age and intrusion symptoms (regression 
coefficient = -0.18 ; p = 0.00) with younger individuals experiencing higher levels of 
intrusive symptoms as compared to their older peers . 
With regard to avoidance symptoms , the EW and GHI groups evidenced similar 
trajectories over time (Figure 6). As seen in Table 19, participant's scores remained 
relatively constant from baseline to 6 months posttreatment (ranging from a mean of 
11.20 to 10.84). Reported avoidance symptoms then sharply decreased from 6 months 
to 1 year for both the EW and GHI groups (EW: M= 7.94, SD= 8.61; GHI: M = 7.75, 
SD= 9.29). 
Table 18 
Linear Mixed Model: Intrusion Symptoms 
Regression 
Variable 
Intercept 
Intervention 
Time 
Age 
Cancer Stage 
Therapy 
Marital Status 
Education 
Prior Disclosure 
* p-value ~ 0.05. 
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18 
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baseline 
coefficient 
19.53 
0.84 
-0.03 
-0.18 
1.49 
-0.44 
-0.58 
0.50 
-0.18 
• 
1 week 
SE 
4 .73 
1.03 
0.01 
0.04 
0.84 
1.27 
1.10 
0.96 
0.17 
4 .13 
0.82 
-3.04 
-4.23 
1.78 
-0.35 
-0.52 
0.52 
-1.06 
4 weeks 
Time 
95% Confidence 
Interval 
,e-value Lower u~~er 
0.00* 10.20 28.86 
0.42 -1.20 2.88 
0.00* -0.06 -0 .01 
0.00* -0.27 -0.10 
0.08 -0.16 3.14 
0.73 -2.95 2.06 
0.60 -2.76 1.60 
0.60 -1.40 2.40 
0.29 -0.52 0.16 
6 months 1 year 
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Figure 6. IES: Mean avoidance scores. Graph depicts overall mean avoidance scores for 
treatment versus control groups from baseline through I-year posttreatment. 
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Table 19 
JES: Mean Avoidance Outcome Scores for EW and GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
IES : Avoidance 
EW 11.10 9.68 10.77 9.64 11.45 9.60 10.37 10.06 7.94 8.61 
GHI 11.20 9.54 11.01 10.92 10.62 10.35 10.84 10.29 7.75 9.29 
Avoidance scores were also examined with regard to the frequency with which 
participants scored at or above the clinical cutoff ( ~O). Approximately one fifth of 
participants evidenced high scores from baseline to 6 months (Table 20), indicating the 
experience of a significant stress response. Furthem1ore, similar to the trajectory for 
intrusion scores , the number of participants who obtained a score within this clinical 
cutoff decreased by about 50% at 1-year postradiation treatment. 
Further exploratory analyses revealed few significant relationships between 
avoidance symptoms and covariates (Table 21 ). Specifically , symptoms of avoidance 
were related to age at the 4-week follow-up (r = -.07, p = 0.03) and to previous therapy 
at baseline (r = -.17, p = 0.02). The experience of avoidance symptoms was consistently 
negatively related to a history of prior disclosure, indicating that a smaller degree of 
prior disclosure was associated with the experience of more avoidance symptoms. 
After exploratory analyses were performed, a linear mixed model was fitted with 
identica l predictor and dependent variables used for the intrusion model (Table 22). The 
Table 20 
Avoidance Subscale: Frequency of Scoring :2: 20 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
TES N % N % N % N % N % 
Avoidance 19 21.4 19 21.4 18 21.6 17 20.8 7 9.9 
Note . Percentages are based on the number of individuals who responded to the IES questionnaire at 
each time point. 
Table 21 
Corre lations Between Avoidance Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
IES: Avoidance 
Baseline 
-.04 (.062) -.0 1 (0.90) -.17 (0.02)* .12(0.12) -.07 (0.38) -.21 (0 .00)* 
I week 
-.09 (0.27) .07 (0.36) ~.13 (0.10) .09 (0.24) -.09 (0.25) -.26 (0.00)* 
4 weeks 
-.17 (0.03)* .05 (0.51) -.10 (0.20) .07 (0.38) -.08 (0.28) -.22 (0.00)* 
6 months 
-.14 (0.08) .07 (0.36) -.03 (0.67) -.05 (0.50) -.03 (0 .73) -.23 (0.00)* 
I year 
-.14 (0.11) .11 (0.18) -.05 (0.55) -.02 (0.83) -.04 (0.68) -.25 (0.00)* 
* p-value s 0.05. 
model failed to reveal a significant treatment effect (Regression Coefficient = -0.13, 
p = 0.91). However, all participants evidenced significant improvements in avoidance 
symptoms over time (Regression Coefficient= -0.04, p = 0.00). History of prior 
disclosure was also significantly related to avoidance symptoms (regression 
coefficient= -0.77,p = 0.00). 
SIP. Exploratory analyses on limitation in the area of home management 
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revealed a decline in limitation over time with a sharper decrease from 1 week to 1 year 
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Table 22 
Linear Mixed Model: Avoidance Symptoms 
95% Confidence 
interval 
Regression 
Variable coefficient SE 2-value Lower Ueeer 
Intercept 23.71 5.589 4.25 0.00* 12.69 34.74 
Intervention -0.13 1.22 -0.11 0.91 -2.55 2.28 
Time -0.04 0.01 -3.45 0.00* -0.06 -0.02 
Age -0.07 0.05 -1.34 0.18 -0.17 0.03 
Cancer stage 0.31 0.99 0.3 1 0.76 -1.64 2.25 
Therapy -2.43 1.49 -1.63 0.11 -5.38 0.51 
Marital status 1.45 1.31 1.11 0.27 -1 .14 4 .03 
Education -0.98 1.14 -0.86 0.39 -3.23 1.27 
Prior disclosure -0.77 0.21 -3.74 0.00* -1.17 -0.36 
* p-value ~ 0.05. 
postradiation treatment (Figure 7). No significant differences were found between the 
EW and GHI groups at baseline (t = 0.95, p = 0.34) and both groups shared a similar 
change trajectory across time. As discussed previously, SIP scores are reported as a 
percentage of limitation. Therefore, participants evidenced a decrease in limitation in 
home management activities from being about 50% limited to a limitation of less than 
25% (Table 23). That is, their limitation in this area of general functioning improved by 
50% over the year following radiation treatment. 
With regard to the relationship between limitation in home management 
activities and specific covariates, analyses indicated several notable relationships (Table 
24). Functioning in home management was significantly related to cancer stage in an 
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Figure 7. SIP: Mean home management scores. Graph depicts overall mean Home 
Management scores for treatment versus control groups from baseline through 1-year 
posttreatment. 
Table 23 
SIP: Mean Home Management Outcome Scores for EWand GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
IES: Home mana geme nt 
EW 47.65 34.16 46.96 36.58 40.01 37.79 34.74 37.87 22.62 33.75 
GHI 52.22 30.19 48.33 36.28 41.25 34.84 33.95 36.79 24.89 34.20 
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Table 24 
Correlations Between Home Management Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
SIP: Home management 
Baseline 
-.02 (0. 76) .21 (0.00)* -.16 (0.03)* .04 (0.58) -.20(0.01 )* -.03 (0.67) 
I week .03 (0.73) .17 (0.03)* -.01 (0.87) -.04 (0.64) -.20 (0.01)* .03 (0. 70) 
4 weeks 
-.09 (0.26) .20 (0.01)* -.18 (0.02)* -.23 (0.00)* -.09 (0.24) .03 (0.73) 
6 months .02 (0.80) .16 (0.05)* -.16 (0.04)* -.14 (0.07) -.06 (0.45) -.02 (0.80) 
I year .13(0.13) .07 (0.43) -.15 (0.07) -.11 (0.20) -.04 (0.65) .08 (0.33) 
* p-value ~ 0.05. 
expected direction, with more advanced cancer related to increased limitation in this 
area at baseline (r = .21, p 0.00) through the 6-month follow-up (r = .16, p = 0.05) . 
Results indicated a small relationship between previous therapy and home management, 
in that those with a history of previous therapy experienced less limitation as compared 
to those with no psychotherapy history. This relationship was significant at baseline 
(r = -.16, p = 0.03), 4 weeks (r = -.18, p = 0.02), and 6 months (r = -.16, p = 0.04). In 
addition, education was negatively related to home management at baseline (r = -.20, 
p = 0.01) and 1 week only (r = -.20,p = 0.01), meaning that those with lower levels of 
education tended to evidence greater limitation in this area. Lastly, marital status was 
negatively related to home management at 4 weeks (r = -.23, p = 0.00), indicating being 
single at the time of the study was related to greater limitation in this area of functioning 
as compared to being married or cohabitating. 
After exploratory analyses were performed, a linear mixed model was fitted with 
the seven predictor variables of time, age, stage, previous therapy, marital status, 
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education, and prior disclosure and one dependent variable of home management. Fixed 
effects (between-subjects factor) within the model included home management group 
means for EW and GHI. Random effects (within-subjects factor) included individual 
participant variables and the intercept. A residual tem1 was also included in the model, 
which allowed for random intercepts. As shown in Table 25, no significant intervention 
effect was found (regression coefficient= -1. 76, p = 0.62). However, participants 
evidenced significant improvement in home management limitations across time 
(regression coefficient= -0.39, p = 0.00). Furthermore, several covariates predicted this 
change over time. Specifically, breast cancer stage (regression coefficient= 8.40, 
p = 0.00), previous therapy (regression coefficient= -10.69,p = 0.02), and education 
(regression coefficient= -8.85,p = 0.01) were significantly related to outcome. 
Table 25 
Linear Mixed Model: Hom e Management 
95% Confidence 
interval 
Regression 
------
Variable coefficient SE p-value Lower Upper 
Intercept 67.68 16.24 4.17 0.00* 35.63 99.74 
Intervention -1.76 3.57 -0.49 0.62 -8.80 5.29 
Time -0.39 0.54 -7.26 0.00* -0.50 -0.29 
Age 0.17 0.15 0.16 0.25 -0.12 0.46 
Cancer stage 8.40 2.88 2.92 0.00* 2.72 14.09 
Therapy -10.69 4.37 -2.45 0.02* -19.30 -2.07 
Marital status -5.12 3.81 -1.35 0.18 -12.64 2.39 
Education -8.85 3.31 -2.67 0.01 * -15.39 -2.31 
Prior disclosure 0.35 0.60 0.59 0.56 -0.82 1.52 
* p-value ::;; 0.05. 
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Exploratory analyses related to the mobility subscale of the SIP revealed unique 
changes over time (Figure 8). No significant differences were found between the EW 
and GHI group at baseline (t = 0.77,p = 0.44). As seen in Table 26, at I-week 
postradiation treatment both groups reported an increase in mobility limitations (EW: 
M = 23.27, SD= 32.94; GHI: M = 30.92, SD= 35.93), with the GHI group experiencing 
a greater increase in limitation. Both groups subsequently reported consistent decreases 
in limitation at 4 weeks (EW: M= 21.28, SD= 33.36; GHI: l'vf= 18.27, SD= 29.67), 6 
months (EW: M= 12.71, SD= 27.33; GHI: M= 13.29, SD= 28.73), and 1 year (EW: 
M= 10.21, SD= 23.11; GHI: M= 9.75, SD= 25.31) . Overall, participants evidenced a 
range of 12-16% improvement in functioning in the area of mobility across the year 
follow-up. 
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Figure 8. SIP: Mean mobility scores. Graph depicts overall mean Mobility scores for 
treatment versus control groups from baseline through I-year posttreatment. 
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Table 26 
SIP: Mean Mobility Outcome Scores for EW and GHI Groups 
Time 
Baseline l week 4 weeks 6 months l year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
SIP: Mobility 
EW 21.86 32.31 23.27 32.94 21.28 33.36 12.71 27.33 10.21 23.11 
GHI 25.69 33.75 30.92 35.39 18.87 29.67 13.29 28.73 9.75 25.31 
Exploratory analyses were then conducted with mobility and the covariates. A 
consistent relationship was found between limitation in mobility and previous therapy 
across all time points (Table 27), indicating that individuals with a history of 
participating in psychotherapy tended to experience decreased limitation in this area. 
Breast cancer stage was found to be positively related to mobility at baseline (r = .24, 
p = 0.00), 1 week (r = .29, 0.00), and 4 weeks (r = .18, p = 0.02), denoting that 
increased limitation is associated with more advanced breast cancer. Lastly , a 
significant relationship was also found between marital status and mobility at the 6-
month follow-up (r = -.19, p = 0.02). 
After exploratory analyses were performed, a linear mixed model was fitted with 
identical predictor and dependent variables used for the home management model 
(Table 28). Analyses indicted that the model found no significant intervention effect 
(regression coefficient= -1.23, p = 0.69). However, participants evidenced a decrease in 
mobility limitations over time (regression coefficient= -0.25, p = 0.00). Furthermore, 
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Table 27 
Correlations Between Mobility Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
SIP: Mobility 
Baseline 
-.12 (0.11) .24 (0.00)* -.17 (0.03)* -.10 (0.21) -.12 (0 .12) .02 (0.81) 
I week 
-.05 (0.52) .29 (0.00)* -.26 (0.00)* .00 (0.96) -.04 (0.64) .09 (0.25) 
4 weeks 
-.07 (0 .34) .18 (0.02)* -.18 (0.02)* .05 (0.55) -.05 (0.48) -.06 (0.43) 
6 months .06 (0.46) .03 (0.71) -.18 (0.02)* -.19 (0.02)* .03 (0.74) .04 (0.64) 
I year 
-.01 (0 .87) .05 (0.59) -.24 (0.01)* -.01 (0.95) .00 (0.96) .02 (0.85) 
* p-value s 0.05. 
Table 28 
Linear Mixed Model: Mobility 
95% Confidence 
interval 
Regression 
Variable coefficient SE p-value Lower Upper 
Intercept 42 .20 13.93 3.03 0.00* 14.68 69.73 
Intervention -1.23 3.06 -0.40 0.69 -7.28 4.81 
Time -0.25 0.69 -5 .17 0.00* -0.34 -0.15 
Age 0.13 0.13 1.01 0.32 -0 .12 0.38 
Cancer stage 4.60 2.50 1.84 0.07 -0.34 9.73 
Therapy -13.65 3.78 -3.61 0.00* -21.12 -6.18 
Marital status -2 .53 3.26 -0.78 0.44 -8.97 3.91 
Education -2.87 2.85 -1.01 0.32 -8.49 2.76 
Previous disclosure 0.12 0.51 0.24 0.81 -0.88 1.13 
* p-value s 0.05 . 
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history of previous therapy was found to predict improvements over time (regression 
coefficient= -13.65,p = 0.00). 
Exploratory analyses for the recreation and pastimes subscale of the SIP 
revealed that the EW and GHI groups were significantly different at baseline (t = 2.61, 
p = 0.01). However, due to including random effects within the linear mixed model, this 
baseline difference was controlled for, making interpretations of findings possible. With 
regard to the trajectory of change across time (Figure 9), the EW group evidenced a 
steady decrease in limitation in recreation and pastimes . The GHI group experienced an 
increase in limitation in this area of functioning at I-week postradiation treatment , but 
then sharply decreased in limitation through the one year follow-up (Table 29). 
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Figure 9. SIP: Mean recreation and pastime scores. Graph depicts overall mean 
recreation and pastimes scores for treatment versus control groups from baseline 
through I-year posttreatment. 
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Table 29 
SIP: Mean Recr eation and Pastimes Outcome Scores for EW and GHI Groups 
Time 
Baseline 1 week 4 weeks 6 months 1 year 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
SIP : Recreation and pastimes 
EW 38.01 31.82 41.02 32.18 36 .64 33 .19 31.89 32 .22 20 .99 29.56 
GHI 49.83 28.20 42 .50 33 .51 35.90 34.29 28 .32 32.53 19.86 29 .33 
Exploratory analyses were conducted to determine the relationship between 
limitation in the area ofrecreation and pastime and covariates (Table 30). A significant 
relationship was found for cancer stage with greater limitation associated with more 
adv anced stage breast cancer (1 week: r = .18, p = 0.02; 4 weeks: r = .25, p = 0.00; 6 
months : r = .18, p = 0.03). A significant relationship was also found for previous 
therap y at 4 weeks (r = -.18, p = 0.02) and 1 year (r = -.25 , p = 0.00) postinterv ention. 
After exploratory analyses were performed, a linear mixed model was fitted with 
the same seven predictor variables (time , age , stage, previous therapy, marital status, 
education , prior disclosure) and one dependent variable (PA) as used in previous 
models (Table 31). Fixed effects (between-subjects factor) within the model included 
recreation and pastimes group means for EW and GHI. Random effects (within-subjects 
factor) included individual participant variables and the intercept. Particularly important 
to this model, a residual term was included, which allowed for random intercepts and 
controlled for the baseline difference. The model revealed no significant intervention 
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Table 30 
Correlations Between Recreation and Pastime Scores and Covariates 
Cancer Previous Marital Prior 
Outcome Age stage therapy status Education disclosure 
SIP: Recreation & Pastime 
Baseline 
-.10 (0 .24) .14 (0.07) -.11(0 .16) .03 (0.67) -.05 (0.53) .05 (0.51) 
I week 
-.13 (0.10) .18 (0.02)* -.11(0 .14) -.05 (0 .50) -.05 (0.53) .01 (0.87) 
4 weeks 
-.08 (0.33) .25 (0.00)* -.18 (0.02)* -.05 (0.50) .02 (0 .84) .03 (0.65) 
6 months 
-.04 (0.59) .18 (0.02)* -.13 (0.10) -.14 (0.07) -.03 (0 . 75) .07 (0.40) 
I year 
-.08 (0.34) .14(0.ll) -.25 (0.00)* -.02 (0.86) -.08 (0.34) .05 (0.53) 
* p-value ~ 0.05. 
Table 31 
Lin ear Mixed Model: Recreation and Pastime 
95% Confidence 
Interval 
Regression 
Variable coefficient SE p-value Lower Upper 
Intercept 53.93 15.80 3.41 0.00* 22.74 85.12 
Intervention -1.36 3.47 -0.39 0.70 -8.21 5.50 
Time -0.38 0.05 -7.18 0.00* -0.48 -0 .28 
Age -0.05 0.14 -0.32 0.75 -0.33 0.24 
Cancer stage 7.78 2.81 2.77 0.01 * 2.23 13.34 
Therapy -8.66 4.26 -2.03 0.04* -17.07 -0.25 
Marital status -2.69 3.70 -0.73 0.47 -10 .00 4.61 
Education -3.28 3.22 -1.02 0.31 -9.64 3.08 
Previous disclosure 0.50 0.58 0.87 0.39 -0.64 1.64 
* p-va lue ~ 0.05. 
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effect (regression coefficient= -1.36, p = 0. 70). However, both groups of participants 
significantly improved over time (regression coefficient= -0.38, p = 0.00). Furthermore, 
breast cancer stage (regression coefficient= 7.78,p = 0.01) and previous therapy 
(regression coefficient= -8.66, p = 0.04) significantly predicted outcome, in that more 
advanced stage breast cancer predicted greater limitation and previous therapy predicted 
decreases in limitation over time. 
Summa ry. To summarize the findings for the first research question , the 
expressive writing intervention evidenced a significant positive impact on reported PA . 
No significant intervention effects were found for the other outcome measures . 
However, both the EW and GHI groups demonstrated significant improvements in NA, 
intrusion and avoidance symptoms, and limitations in home management, mobility , and 
recreation and pastime over time. 
Linguistic Analyses 
Prior to answering the second research question , descriptive analyses were 
conducted on the expressive writing narratives. Utilizin g the LIWC program , the mean 
percent of words utilized from particular linguistic categories was first determined (see 
Tables 32 and 33) . Participants wrote an average of 473 words during each of the three 
writing sessions (range= 19-1,644). The total word count of the narratives decreased 
significantly from the first to the third writing session (writing 1 to writing 2: t = 4.68, 
p = 0.00; writing 2 to writing 3: t = 2.93 , p = 0.01) . 
With regard to affect when averaging across the three writing sessions, less than 
5% of total words used were positive or negative emotion words (positive emotion: 
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Table 32 
Linguistic Analyses of Expressive Writing Narratives: Part I 
Positive emotion Negative emotion 
Total words words words Cog nitive words 
Mean Mean Mean Mean 
Writing session % range % range % range % range 
Writing I (N = 68) 566.55 119-1644 2.32 0.37-4 .91 2.09 0.33-4.73 7.56 3.20-11.77 
Writing 2 (N = 65) 466.88 47-1314 2.90 0.00-8.49 2.01 0.00-6.72 7.40 1.60-12.77 
Writing 3 (N = 66) 401.11 19-1461 3.22 0.00-13.23 1.94 0.00-10.53 7.36 3.30-13 .04 
Combined writings 473.02 71-1252 2.80 0.00-13.23 2.02 0.00-10.53 7.46 1.60- 13.04 
(N= 200) 
Table 33 
Linguistic Analyses of Expressive Writing Narratives: Part II 
Tense 
Past Present Future 
Writing session Mean% range Mean % range Mean% range 
Writing I (N = 68) 7 58 0.84-13.82 9.82 3.07-22.69 1.03 0.00 -3 63 
Writing 2 (N = 65) 6.05 0.36-11.36 I 1.14 3.27-25.53 1.30 0 .00-4.58 
Writing 3 (N = 66) 5 18 0.00-15 79 13. 12 5.08-21.74 1.44 0.00-4.55 
Comb ined wr itings 6 27 0.00-15.79 11.35 3.07-25.53 1.25 0.00-4.58 
(N = 200) 
mean= 2.80%; negative emotion: mean = 2.02%). Participants utilized significantly 
more positive emotion words than negative emotion words (t = 4.1 O; p = 0.00). 
Furthermore, participants' use of positive emotion words increased across writing 
sessions, but only reached significance for the difference between the first and second 
writing session (writing 1 to writing 2: t = -2.94; p = 0.01; writing 2 to writing 3: 
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t = -1.68; p = 0.10). The use of negative emotion words appeared to stay relatively 
constant across sessions (writing 1 to writing 2: t = .29;p = 0.77; writing 2 to writing 3: 
t = .53; p = 0.60). When averaging across all three writing sessions, participants utilized 
more cognitive words (mean= 7.46%) than affect words. The use of cognitive words 
also remained constant across writing sessions (writing 1 to writing 2: t = .18; p = 0.86; 
writing 2 to writing 3: t = .08; p = 0.94). 
The examination of verb tense revealed that the majority of participants 
produced narratives characterized by more present tense words (mean= 11.35%) than 
past tense (mean= 6.27%) or future tense words (mean = 1.25%) when averaged across 
the three writing sessions. Analyses of change in verb tense over time indicated a 
significant decrease in past tense verbs (writing 1 to writing 2: t = 3.84; p = 0.00; 
writing 2 to writing 3: t = 1.97; p = 0.05), an increase in present tense verbs (writing 1 
to writing 2: t = -3.16; p = 0.00; writing 2 to writing 3: t = -3.40; p = 0.00), and an 
increase in the use of future tense verbs, which was significant only from the first to the 
second writing session (writing 1 to writing 2: t = -2.17; p = 0.03; writing 2 to writing 3: 
t = -.58; p = 0.57). 
After determining the linguistic content of the narratives, analyses specific to the 
second research question were performed. The second research question sought to 
ascertain the relationship between the use of various linguistic variables (i.e., positive 
emotion words, negative emotion words, cognitive words, and verb tense) and outcome 
(i.e., PA, NA, intrusion and avoidance symptoms, general functioning). In order to 
answer this research question, 2-tailed pairwise Pearson R correlations were conducted 
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with seven linguistic variables and seven outcome variables, including the PANAS, 
IES, and SIP. Some caution in interpreting these relationships should be employed due 
to the large number of correlations conducted and thus, the increased risk of Type I 
error. However, these analyses should be considered exploratory in nature and used to 
provide truly preliminary infonnation on the relationships between outcome and 
linguistic variables. 
With regard to the PANAS, scor es from the NA and PA subscales were 
analyzed separately (Table 34) . Positive emotion words were significantly positively 
related to PA at 1-week posttreatment (r = .24; p = 0.05) . Negative emotion words were 
found to be significantly negatively correlated with PA at 6-months posttreatment 
(r = -.25; p = 0.04). The use of negative emotion words was positively correlated with 
NA at the 1-week follow-up (r = .33 ;p = 0.01) . Analyses further revealed a significant 
negative relationship between the use of cognitive words and PA at 1-year 
posttreatment (r = -.263 ;p = 0.05) . Finally , the use of past tense words was found to 
have a significant negative relationship with NA at 6-months posttreatment (r = -.24; 
p = 0.05), indicating NA decreases with the use of past tense words. No relationship 
was found between NA and the use of cognitive words or present and future tense 
words. 
Analyses revealed additional significant relationships between linguistic 
variables and avoidance and intrusion symptoms (Table 35). The use of negative 
emotion words was found to have a significant positive relationship with intrusion 
symptoms at 4 weeks (r = .32; p = 0.01) and 6 months (r = .26;p = 0.03) . The use of 
Table 34 
PANAS: Relationship Between Linguistic Variables and PA and NA 
PA 
1 week 4 weeks 6 months 1 year 
Linguistic category R p R p R p R p 
Word count .18 .14 .10 .43 -.13 .30 .08 .56 
Positive emotion .24 .05* -.02 .85 .05 .67 -.03 .84 
Negative emotion -.12 .32 -.12 .34 -.25 .04* -.20 .15 
Cognitive -.14 .27 -.09 .50 -.03 .82 -.26 .05* 
Tense 
Past -.01 .92 -.05 .69 .01 .96 -.08 .57 
Present -.08 .52 -.05 .72 -.04 .73 -.10 .48 
Future .06 .65 .06 .66 .06 .66 .14 .32 
* p-value ~ 0.05. 
1 week 4 weeks 
R p R p 
-.04 .77 .00 .99 
-.06 .65 -.09 .49 
.33 .01 * .19 .14 
.07 .60 -.0 1 .96 
-.19 .12 -.02 .88 
.18 .14 -.07 .56 
.08 .50 .14 .28 
NA 
6 months 
R p 
-.02 .87 
.03 .80 
.20 .12 
.11 .40 
-.24 .05* 
.20 .12 
.06 .62 
1 year 
-
R p 
-.10 .47 
.11 .44 
.11 .41 
.21 .13 
-.10 .46 
.18 .19 
-.01 .96 
........ 
0 
N 
Table 35 
JES: Relationship Between Linguistic Variables and Intrusion and Avoidan ce Sy mptoms 
Intrusion Avoidance 
1 week 4 weeks 6 months 1 year I week 4 weeks 6 months 
Linguistic category R p R p R p R p R p R p R p 
Word count .04 .76 .00 .99 .08 .53 .12 .37 -.04 .77 .02 .86 -.05 .72 
Positive emotion -.14 .26 -.09 .49 .07 .59 .09 .53 -.07 .56 -.06 .64 .16 .21 
Negative emotion .10 .42 .32 .01 * .26 .03* .12 .37 -.01 .94 .14 .28 .15 .24 
Cognitive -.04 .78 .06 .66 .10 .41 .19 .17 .09 .45 .02 .89 .07 .58 
Tense 
Past -.06 .65 -.05 .70 -.08 .52 -.11 .44 .01 .94 -.14 .25 -.27 .03* 
Present -.11 .88 -.00 .99 .02 .89 .01 .92 .04 .76 .12 .35 .25 .05* 
Future .16 .20 .04 .74 .13 .31 -.07 .60 .13 .31 .04 .73 .15 .24 
* p-value :;; 0.05. 
I year 
--
R p 
.02 .89 
.18 .18 
.10 .49 
.15 .29 
-.27 .05* 
.25 .07 
.20 .15 
...... 
0 
I.,.) 
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past tense words was negatively related to avoidance symptoms at 6 months (r = -.27; 
p = 0.03) and 1-year (r = -.27; p = 0.05) posttreatment. Furthermore , the use of the 
present tense was positively related to avoidance symptoms at 6 months follow-up 
(r = .25; p = 0.05). 
With regard to the SIP, specific linguistic variables were not found to be related 
to household management activities or recreation and pastime activities (Tables 36 and 
37). However , total word count at 4 weeks and 6 months was positively related to 
mobility . The SIP score represents the percent of limitation in that area of general 
functioning, indicating that as total word count increased limitation in mobility also 
increased. 
Prior Disclosure 
Prior to answering the last research question, descriptive analyses were 
performed on reported history of prior disclosure (Table 38). This measure consisted of 
one question that asked participants to rate how much they had disclosed (i.e., through 
talking or writing) their deepest thoughts and feelings related to their cancer and cancer 
treatment. They rated their prior disclosure on a scale ranging from 0, not at all, to 10 
compl etely. To summarize the rating scale into more meaningful and interpretable 
categories, responses from O to 3 are interpreted as little disclosure, 4 to 7 as moderate 
disclosure, and 8 to 10 as high disclosure. Just over half (53 .6%) of participants 
indicated disclosing to a large degree prior to entering the study. One third (29.6%) 
reported moderate disclosure and just over 15% said they had disclosed relatively little. 
Table 36 
SIP: Relationship Between Linguistic Variables and General Health (Part 1) 
Household management 
1 week 4 weeks 6 months 1 year I week 
Linguistic category R p R p R p R p R p 
Word count .14 .25 .01 .95 .01 .93 -.14 .32 .13 .32 
Positive emotion -.11 .39 .05 .72 -.16 .21 .12 .40 -.01 .92 
Negative emotion .10 .44 .03 .83 -.04 .76 .06 .69 .21 .09 
Cognitive .06 .64 .07 .59 .06 .62 -.17 .23 .04 .77 
Tense 
Past .24 .06 .08 .51 .05 .67 -.01 .96 .07 .60 
Present -.13 .30 -.01 .96 .08 .54 .01 .96 .02 .90 
Future -.13 .30 -.01 .96 .08 .54 .01 .96 .02 .90 
* p-value ~ 0.05. 
Mobility 
4 weeks 6 months 
-
R p R p 
.24 .05* .42 .00* 
-.10 .45 -.10 .42 
.00 .98 -.14 .26 
.12 .34 .00 .98 
.14 .28 .15 .22 
-.12 .34 -.06 .66 
-.12 .34 -.06 .66 
1 year 
R p 
.02 .89 
.02 .92 
.03 .85 
-.09 .52 
.15 .27 
-.00 .99 
-.00 .99 
....... 
0 
Vl 
Table 37 
SIP: Relationship Between Linguistic Variables and General Health (Part II) 
Recreation and pasttime 
1 week 4 weeks 6 months 
Linguistic category R p R p R p 
Word count .20 .11 .17 .18 .21 .10 
Positive emotion -.07 .58 .04 .78 -.09 .48 
egative emotion .03 .82 .16 .21 .06 .63 
Cognitive .18 .15 .24 .OS .15 .23 
Tense 
Past -.OS .69 .02 .90 -.08 .54 
Present .14 .28 .04 .77 .13 .30 
Future .06 .64 .01 .91 .03 .80 
* p-value ::; 0.05. 
Table 38 
Summary of Prior Disclosure 
DIS (N = 179) 
Rating 
0-3 (little) 
4-7 (moderate) 
8-10 (high) 
n 
30 
53 
96 
% 
16.8 
29.6 
53 .6 
1 year 
R p 
-.01 .94 
.15 .28 
.04 .77 
.00 .98 
-.1 S .27 
.18 .21 
.10 .49 
The final research question asked whether a relationship exists between 
perception of prior disclosure at baseline and positive and NA (PANAS), general 
functioning (SIP: Home management, mobility, recreation and pastimes), or trauma-
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related symptoms (RIES: Intrusion and avoidance) at baseline or follow-up. In order to 
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answer this research question, history of prior disclosure was included as a covariate in 
all previously presented linear mixed models. In addition, further exploratory analyses 
were performed. Specifically, 2-tailed pairwise Pearson R correlations were conducted 
with DIS and outcome, including PANAS, SIP, and RIES (Table 39). Results reveal a 
significant positive relationship between perception of prior disclosure and PA at 
baseline (r = .18, p = 0.02), 1 week (r = .19, p = .01), 4 weeks (r = .17, p = 0.02), and 6 
months (r = .17, p = 0.03) follow-up, indicating that as perception of prior disclosure 
increased so did PA. A negative relationship was found between perception of prior 
disclosure and avoidance symptoms at baseline (r = -.21,p = 0.00), 1 week (r = -.21, 
p = 0.00), 4 weeks (r = -.22, p = 0.00), and 1 year (r = -.25, p = 0.00) follow-up, 
Table 39 
Relationship Between Perception of Prior Disclosure and Outcome 
Time 
I week 4 weeks 6 months I year I week 
Outcome variable R p R p R p R p R p 
PANAS 
PA .183* .0 15 .188* .014 .174* .022 .165* .034 082 .322 
NA -.131 .083 -.045 .562 -.057 .459 -.073 .352 -.115 .176 
SIP 
Hou sehold mgmt . -.032 .674 .030 .698 .027 .726 -.020 .799 .084 .327 
Mobility .018 .814 .089 .247 -.06 1 .425 .037 .636 .017 .845 
Recreation /Pastime .050 .5 12 .013 .867 .034 .653 .066 .399 .054 .528 
RIES 
Avoidance -.214* .004 -.214* .004 -.224* .003 -.230 .003 -.251 * .003 
Intrusion -. I 04 .168 -.104 .168 -.066 .396 -.077 .326 -.099 .245 
* p-value ~ 0.05. 
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indicating that lower levels of prior disclosure are associated with increased avoidance 
symptoms . No relationship was found between perception of prior disclosure and NA, 
general functioning, or intrusion symptoms. 
CHAPTER V 
DISCUSSION 
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The primary aim of the present study was to determine the effects of an 
expressive writing intervention on the emotional and physical well-being of breast 
cancer patients as compared to a treatment-as-usual control group. The secondary aim 
of the study was to examine the linguistic content of expressive writing narratives. This 
study specifically examined three research questions . The following presents a 
summary ofresults, relates the current study findings to previous research , presents 
implications and limitations of the project , as well as future directions . 
Summary of Findings 
The first research question asked, "Does an expressive writing intervention 
impact PA, NA, intrusion and avoidance symptoms , or general functioning as compared 
to a general health information control?" In order to answer this question , a series of 
linear mixed models were conducted. Results revealed a significant treatment effect for 
PA , indicating that the EW group evidenced significantly greater improvement in PA 
over time in relation to the GHI group. The GHI group also showed significant 
improvements in PA across time. No other intervention effects were found for the other 
outcome measures. However, analyses revealed that individuals in both the EW and the 
GHI groups reported significant improvements on all outcomes over time , including 
NA , intrusion and avoidance symptoms , and general functioning (home management, 
mobility, recreation and pastimes). Based on this finding it is difficult to determine 
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whether participants felt better as a function of time, or whether they evidenced 
improvements as a result ofreceiving the EW and GHI interventions. Unfortunately, 
without having a nonintervention or neutral writing control, this determination cannot 
be made. This will be discussed in further detail later in the discussion. With regard to 
the covariates examined within each model, several significant effects were found. 
Specifically, more advanced breast cancer was associated with lower PA , higher NA, 
and greater limitation in home management and recreation and pastimes. It should be 
noted that participants within the study had stage I, II, or III breast cancer (individuals 
were excluded from the study if they had stage IV cancer). Therefore, "more advanced 
stage cancer" is specific to participants of this study, as opposed to individuals with 
stage IV (advanced stage) cancer. Moreover, it appears that individuals with more 
advanced breast cancer tend to experience overall decreased psychological well-being 
and have a lower level of general functioning. Additionally, perceived prior disclosure 
at baseline was found to be related to positive long-term effects on measures of 
psychological well-being. Specifically , a greater history of prior disclosure was 
associated with higher PA, and a smaller degree of prior disclosure was related to the 
experience of more avoidance symptoms . Younger age was also associated with greater 
intrusion symptoms. Having a history of participating in previous therapy was 
associated with decreases in limitations in the areas of home management, mobility, and 
recreation and pastimes across time . Lastly, having a higher level of education was 
related to decreases in limitations in home management. 
The second research question asked, "What are the relationships between the use 
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of positive words, negative words, cognitive words, and verb tense across the three 
writing sessions with PA, NA, intrusion and avoidance symptoms, and general 
functioning?" Analyses indicated few and inconsistent relationships. For instance, the 
use of negative emotion words was negatively related to PA at 6 months, and positively 
related to NA at 1 week. This suggests that the use of negative emotions words is 
related to decreases in PA and increases in NA. This is as would be expected in that 
one's choice of emotionally charged words seemed to reflect one's emotional state (or 
vice versa) . Findings also indicated that NA tended to decrease with the use of past 
tense verbs . PA also tended to decrease with the use of cognitive words. With regard to 
intrusion and avoidance symptoms, the use of negative emotion words was related to 
increases in intrusion symptoms. The use of past tense verbs was also related to 
decreases in avoidance symptoms, whereas the use of present tense verbs was 
associated with the increase of avoidance symptoms. Concerning the relationship 
between the primary linguistic components analyzed and general functioning , no 
significant relationships were found. The relationship between linguistic variables and 
outcome measures should be interpreted as preliminary and exploratory, due to the large 
number of correlational analyses that were conducted and due to the inconsistent 
findings across time (i.e ., significant relationships were often found at only one of the 
four postintervention follow-up periods). Overall, they should also be interpreted with 
caution. 
General descriptive linguistic analyses revealed that the use of PA words tended 
to increase across writing sessions, whereas the use of NA words and cognitive words 
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tended to remain constant across the three writing sessions . With regard to verb tense, 
the use of past tense verbs decreased across writing sessions, but the use of present and 
future tense words increased . Overall, participants utilized more present tense words 
than future or past and more future tense words than past tense words. 
Finally, the third research question asked , "Is perception of prior disclosure at 
baseline related to intrusion and avoidance symptoms, PA, NA, or general functioning 
at baseline and follow-up?" This question was primarily answered within the first 
research question , as prior disclosure was included within each linear mixed model as a 
covariate . However, results will be briefly reiterated here. Overall, perceived prior 
disclosure at baseline was found to be related to positive long-term effects on measures 
of psychological well-being (i.e., PA , avoidance symptoms) , but not related to general 
functioning. General descriptive findings revealed that most participants reported a 
history of disclosing thoughts and feelings related to their cancer experience. However , 
up to one third of participants had only moderately disclosed up to that point , with 15% 
disclosing very little to not at all. 
Integration of Current Findings and Related Literature 
The majority of existing expressive writing studies focusing on patients with 
general cancers , found no effect of an expressive writing intervention on psychological 
well-being (de Moor et al., 2002 ; Rosenberg et al., 2002). However, these studies 
utilized predominantly male participants. One study utilizing relatively equal numbers 
of males and females found the expressive writing intervention to be related to a 
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decrease in avoidance behaviors at 6 months postintervention (Zakowski et al., 2004). 
Unfortunately, the researchers did not assess affect. Studies examining the impact of 
such an intervention on breast cancer patients revealed positive effects on physical 
health (Stanton et al., 2002), but no effects on psychological well-being (Stanton et al.; 
Walker et al., 1999). Overall, previous research continues to be mixed with regard to the 
impact of expressive writing on psychological well-being. However, it is important to 
note that , aside from the contrasts in gender across most previous studies and the 
present project, the studies that found no impact on psychological well-being utilized a 
low number of participants (N = 15-21) in each intervention group ( de Moor et al.; 
Rosenberg et al.; Stanton et al.; Walker et al.). This may have also impacted the ability 
of their findings to reach statistical significance. The present study adds to the 
controversy of findings in this area in that the expressive writing intervention was 
significantly related to increased PA over time , but umelated to intrusion and avoidance 
symptoms . Individuals who were randomized to receive the expressive writing 
intervention reported significantly greater postintervention gains in PA as compared to 
the GHI group. Differences were consistent even when controlling for a variety of 
covariates (i.e., age, cancer stage, previous therapy, marital status , education, prior 
disclosure) that were thought to potentially influence outcome. Further research is 
needed to help clarify whether women with breast cancer can gamer benefit from 
expressive writing and in what specific domains (e.g., psychological well-being, 
physical health, general functioning) may be impacted by such an intervention. 
With regard to linguistic trends, the present study found an increase in PA words 
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across sessions, but no change in NA words. Despite future research being warranted, 
these findings may help to somewhat resolve contradictions across previous studies. 
That is, Pennebaker (1993) found participants who evidenced health improvements 
utilized a larger proportion of negative emotion words (i.e., anxiety, sadness) than 
positive emotion words as compared to participants who did not improve. However, that 
finding is not only contrary to the present study's findings, but is also contrary to two 
other primary studies that have employed linguistic analyses in the context of 
expressive writing (Pennebaker & Francis, 1996; Pennebaker et al., 1997). For instance, 
Pennebaker and colleagues found that the use of positive emotion words was related to 
better health. Pennebaker and Francis also found that the more positive emotion words 
participants used, the better their health after the writing intervention. Based on 
previous research, one may speculate that the present study's finding of a significant 
relationship between the use of positive emotion words and PA and the finding that the 
use of positive words increased over time, may have impacted the significant increase in 
PA across the year of follow-up. However, additional research on these relationships is 
warranted. 
The current study found no changes in the use of cognitive words across writing 
sessions, which is in direct conflict with the most consistent linguistic finding reported 
in existing studies. Researchers have specifically reported positive outcomes to be 
related to an increase in the use of cognitive words across writing sessions (Pennebaker, 
1993; Pennebaker & Francis, 1996; Pennebaker et al., 1997). However, these studies 
utilized physically healthy participants. Low and colleagues (2006) examined the 
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linguistic content of expressive writing essays in a breast cancer population and found 
no significant changes in the use of cognitive words across writing sessions. The present 
study found the same result. The failure to find an increase in the use of cognitive words 
with breast cancer patients could be due to a variety of factors. First, it may be related to 
the trauma about which the participants wrote. That is, it may be inappropriate to 
compare findings from a study that examined expressive writing about one's transition 
to college or about being laid off of work, for example, to studies that examined 
expressive writing about one's breast cancer experience . The topic about which one 
writes may help to dictate the specific linguistic components that lead to positive 
outcomes. However, this warrants further study. Furthermore, it can be hypothesized 
that the mere physical condition of having breast cancer, may impact how and what 
participants write about, particularly when compared to healthy controls. Lastly, it 
should be highlighted that this study did find that participants used significantly more 
cognitive words than affective words, which indicates participant's essays were at least 
in part focused on cognitive processing. 
The use of verb tense has not been widely examined in expressive writing 
literature. However, despite few researchers examining this domain, findings seem to be 
consistent across studies, including the present study. Pennebaker and Francis (1996) 
also found a decrease in the use of past tense words across writing sessions in a similar 
study examining a sample of college students. Walker and colleagues (1999) found a 
decrease in past tense words and an increase in present and future tense across writing 
sessions as well. With regard to the present study, participants utilized more present 
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tense verbs than past or future tense verbs. A decrease in past tense verbs and an 
increase in the use of present and future tense verbs across writing sessions was also 
noted. Furthermore, the use of past tense verbs was associated with a decrease in 
avoidance symptoms . Participants were in the process of completing radiation therapy 
for their breast cancer upon entering this study. Given that they were at the end of that 
treatment, and in light of the present findings, it could be hypothesized that the use of 
past tense verbs indicates participants may have been confronting or disclosing about 
previously avoided thoughts and feelings . Once this disclosure took place, it logically 
follows that they might progress to writing about thoughts and feelings related to the 
present time or future. However, again it should be noted that given the exploratory 
nature of the analyses, such hypotheses and conjecture should be interpreted as 
preliminary and contingent upon further study. 
Finally, little research exists that explores disclosure patterns among breast 
cancer patients . However, findings from the present study are commensurate with the 
results of previous investigations. Generally, findings from the current project indicated 
that over 15% of participants reported having disclosed relatively little prior to entering 
the study. This finding is consistent with existing research that reported 15-23% of 
breast cancer patients had disclosed little to family , friends , and medical professionals 
(Henderson et al., 2002). The current project found that having a history of prior 
disclosure was associated with increased PA across both treatment groups. Conversely, 
a history of little prior disclosure was associated with avoidance symptoms. These 
findings suggest what would be expected based on trauma and inhibition theories 
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(Chemtob et al., 1988; Foa et al., 1989; Horowitz, 1986; Pennebaker & Beall, 1986); 
that is, the more one discloses about a distressing event the better one feels, and the 
more one inhibits thoughts and emotions related to such an event the more one 
experiences related avoidance symptoms. Furthermore, in breast cancer patients 
research has demonstrated that inhibiting one's thoughts and feelings related to having 
breast cancer is associated with breast cancer metastasis and with an earlier death 
(Jensen, 1987; Weihs et al., 2000) . 
The present study found a significant effect over time for both the EW and GHI 
groups across all outcome variables. This study also collected data longitudinally for 1 
year postintervention, which is the longest longitudinal study in this area of research. 
One reason the present study may have found significant effects over time is due to 
collecting data over a longer follow-up period . Prior studies examining the effect of 
expressive writing on breast cancer patients collected data longitudinally , but for 7 
months maximally (Walker et al., 1999). The majority of changes in psychological 
well-being that were detected in the present study were not apparent until approximately 
6 months postintervention. For instance, sharp increases in PA were not found until 6 
months posttreatment. With regard to intrusion and avoidance symptoms , participants 
did not evidence substantial declines in symptoms until 1 year posttreatment. If 
participant change was not measured up to 1 year postintervention, the positive changes 
observed may not have been detected. Furthermore, the patterns of change over time 
may look different if not measured longitudinally. For example, participants reported 
decreases in NA at 1 week posttreatment, with little change from 1 week to 6 months. If 
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the follow-up assessments had stopped at 6 months, then the sharp decline in NA from 
the 6 month to the 1 year follow-up would have gone undetected. The trajectory of 
change for NA would have appeared to represent an immediate improvement in 
symptoms and then a leveling off trend, as opposed to what actually occurred, which 
was additional improvement in symptoms after 6 months. It seems that measuring 
participant change longitudinally for at least 1 year was beneficial in revealing 
potentially more accurate changes in functioning over time . 
Limitations 
Both the participants, who received the EW intervention and those who received 
the GHI intervention , evidenced significant improvements on all measures of 
psychological well-being and general functioning across time. This overwhelmingly 
positive finding points to a potential flaw in the way the two groups have been 
described and a potential threat to internal validity. The EW group was considered the 
treatment group and the GHI group was originally described as a treatment-as-usual 
control. However , analyses seem to reveal that the GHI may , in fact, be more accurately 
described as a treatment itself. Breast cancer patients are typically provided with 
general information about what to expect posttreatment and where to find resources 
related to breast cancer and its treatment. However, the GHI group received detailed 
information via audiotape and were provided with a written copy of the information that 
they were instructed to read on the following consecutive two days. Based on the way 
this information was disseminated to patients as well as the detail included in the 
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information, it is speculated that the GHI potentially functioned as a treatment. It 
appears that both interventions were related to positive effects in participants over time. 
Unfortunately, these results can only be described as being associated with outcomes 
and warranting further study. Due to not having a true nontreatment control group, it is 
impossible to determine whether participants' improvements in psychological well-
being and general functioning were due to the treatments themselves or to the passage 
of time , or some other threat to internal validity . Therefore , a major limitation to this 
study is the control group utilized. Cleaner comparisons could have been made if either 
a wait-list or no-intervention control group was utilized. A neutral writing control group 
would have also helped to make more descriptive comparisons. Researchers, who have 
utilized a neutral writing control group, have been better able to make assumptions 
about the effects of the expressive writing intervention (Francis & Pennebaker , 1992; 
Greenberg et al., 1996; Pennebaker et al., 1990; Pennebaker & Francis , 1996). The 
neutral writing control is typically instructed to write about an innocuous subject (e.g., 
describe the room you are sitting in, write about your plans for the day). By utilizing a 
neutral writing control, the participants are essentially engaging in the same task, but 
with a different focus, making assertions about causal versus correlation effects easier. 
Two additional threats to internal validity have been identified. First, 
participants were studied over 1 year of time. During that year, which occurred 
postradiation treatment, participants would have had time to potentially mature or grow 
emotionally and cognitively. This growth or maturation would be particular to having 
completed treatment for a life-threatening illness. Additionally, it is possible that 
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participants experienced or were exposed to something during the year of follow-up 
assessment that impacted their psychological well-being or general functioning and that 
affected outcome. However, participants in both the EW and GHI groups experienced 
similar changes over time suggesting that if they had matured or experienced a 
confounding event , it did not differentially impact outcome. 
The outcome data for this study was entirely based upon self-report measures 
and did not include measures of physical health . Having some objective measure of 
adjustment that could either be corroborated or be obtained independently of 
participants may have added a level of objectivity to outcomes . However, it is noted that 
all self-report measures utilized had adequate reliability and validity . Measures of 
physical health (e.g., medical visits, blood pressure, heart rate) have been demonstrated 
to be useful objective measures of adjustment. In fact, expressive writing has been 
found to positively impact physical health , emphasizing the importance of including 
such objective measures of adjustment (Greenberg & Stone, 1992; Greenberg et al., 
1996; Pennebaker & Beall, 1986; Pennebaker et al., 1988; Petrie et al., 1995). 
In addition , this study was interested in determining the effects of prior 
disclosure on outcome in order to determine who might most benefit from such an 
expressive writing intervention. It may have been even more informative if perception 
of disclosure was also measured after each of the writing sessions . This may have 
provided information about the extent to which participants perceived they disclosed 
during their writing, which in tum may have illuminated the depth of disclosure 
necessary to produce positive outcomes. 
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Finally, with regard to external validity, several potential threats exist. First, the 
majority of participants in the present study were Caucasian. However, this is 
characteristic of the region of the country from which participants were sampled. 
Furthem1ore, it appears to be typical based on other studies utilizing breast cancer 
patients (Stanton et al., 2000, 2002; Walker et al., 1999). The majority of participants 
were also married and had at least a high school education (with many having graduated 
from college). These sample characteristics are also typical of existing research (Stanton 
et al., 2000, 2002; Walker et al.). With regard to cancer stage, the majority of 
participants had either stage I or stage II breast cancer with very few having stage III 
cancer. Research has demonstrated that individuals with more advanced breast cancer 
experience similar rates of depression and anxiety (Kissane et al., 2004), but experience 
higher incidence rates of PTSD as compared to individuals with earlier stage cancer 
(Andrykowski & Cordova , 1998; Andrykowski et al. , 1998; Cordova et al., 1995; 
Jacobsen et al., 1998). Consequently, generalizing results of the present study to 
individuals with higher than a beginning- to middle-stage breast cancer (stage I, II, or 
III) , warrants further research. In addition, all subjects participated in this study at the 
end of their radiation treatment. The time immediately following completion of 
radiation treatment was chosen for this intervention study because it has been found to 
be characterized by distress (Jarrett et al., 1992; Maher, 1982; Walker et al., 1996). 
However, this indicates that generalizing results to breast cancer patients who are in a 
different phase of treatment or recovery warrants additional study. 
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Implications 
Research has revealed that most women with breast cancer have at least 
somewhat discussed their disease with others. However, many disclosed relatively little 
(15-23 %) with others (Henderson et al., 2002). This finding is consistent with the 
present project. Furthermore, previous research indicated that more than half of 
participants wanted at least moderately to discuss their experience with others . 
Conversely, 19% of women said they did not want to talk about their experience at all, 
and 12% at least somewhat wanted to keep their breast cancer a secret (Henderson et 
al.). It appears that most women with breast cancer disclose their thoughts and feelings 
to others . However, there is a subset of women who do not disclose to others and a 
subset who do not want to discuss their experience with other people . It seems that this 
expressive writing intervention is unwittingly tailored specifically to individuals who 
may not want to express their thoughts and feelings about their breast cancer experience 
to others . The writing paradigm provides a confidential , private , outlet that can be used 
to express oneself without the pressure and uneasiness one might feel if discussing such 
a sensitive topic with other people . 
Researchers have demonstrated that the inhibition of breast cancer-related 
thoughts and feelings has been associated with cancer metastasis (Jensen , 1987) and 
with a shortened survival time in recurrent breast cancer patients (Weihs et al., 2000). 
This grim finding is even more worrisome, provided the number of breast cancer 
patients who do not want to discuss their experience with others, including those who 
want to keep their experience a secret (Henderson et al., 2002). However, the 
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expression of cancer-related thoughts and emotions has been associated with positive 
physical and psychological consequences (de Moor et al., 2002; Low et al., 2006; 
Rosenberg et al., 2002; Stanton et al., 2002; Walker et al., 1999; Zakowski et al., 2004). 
Based on this body of literature, it logically can be concluded that breast cancer patients 
should be encouraged to express their thoughts and emotions specific to their cancer 
experience and should be provided with a means to do so. Expressive writing is a 
confidential, noncost prohibitiv e, easy intervention that to date has not evidenced any 
contradictory findings that would not support providing such an intervention to breast 
cancer patients. One might argue that taking 20 to 30 minutes out of one's day to write 
about a potentially emotionally difficult subject could be taxing to the average breast 
cancer patient, particularly if she is experiencing treatment side-effects ( e.g., fatigue; 
King , Nail, Kreamer, Strohl, & Johnson, 1985). However, it may be speculated that the 
potential long-term benefits ( e.g., increased PA, decreased negative physical symptoms, 
decreased medical appointments; Stanton et al., 2002) of the intervention outweigh the 
potential short-term uneasiness that may result from confronting something that may be 
emotionally difficult. 
Future Directions 
It is evident that expressive writing is not only likely beneficial for physically 
healthy individuals, and has also been demonstrated to be potentially beneficial for 
individuals with breast cancer. However, findings remain mixed with regard to the 
specific areas of functioning (i.e., psychological well-being, physiological functioning, 
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physical health) that expressive writing can impart positive effects. Future research 
should employ a range of self-report and objective measures examining multiple areas 
of functioning and adjustment in order to accurately assess how expressive writing can 
impact breast cancer patients. 
Similar to the limitations of the present study, it is recommended that future 
studies examining the effect of expressive writing on breast cancer patients employ a 
true control group or neutral writing comparison group. Furthermore, using at least one 
objective measure of adjustment, particularly a measure of physical health when 
examining expressive writing in breast cancer patients , is recommended. 
A systematic review of expressive writing studies utilizing physically and 
psychologically healthy participants found that those studies that spaced writing 
sessions across a longer time period evidenced more significant outcomes (Smyth, 
1998). The present study had participants write on 3 consecutive days. Despite the 
present study examining breast cancer patients, as opposed to healthy individuals as in 
previous research, further examination of the effect of spacing expressive writing 
sessions across a longer time period is warranted. 
The present study sought to extend the existing and extensive expressive writing 
literature, which has primarily focused on healthy participants, to a breast cancer 
population. Few expressive writing studies have collected data longitudinally. This is 
the first study in the area to collect data up to 1 year postintervention. The significant 
treatment effect on PA at 1 year postintervention, as well as the significant positive 
effect over time on all outcome measures, points to the importance of studying the 
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effects of expressive writing interventions longitudinally. This example of longitudinal 
research design will hopefully provide a jumping off point for future research on 
expressive writing. 
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Principal lnvestigator{Program Director (last, first , middle}: Nail. Lillian M. 
cSCRIP TION. State the application's broad, long·term object ives and soecific aims, making reference to the health relatedness of the projec t. 
gsc rib e concise ly the resear ch design and methods for achieving these goals. Avoid summaries ot past ac;compfishments and use of the first person. 
""'lis description is meant 10 serv e as a succinct and accurate description of the proposed work when separated from the .application. If the 
Jpli- ·r- •s funded, this description , as is, w ill become public information. Therefore, do not include proprietary/ confidential information. DO NOT 
'· SPACE PROVIDED . 
Thn randomized clinical trial tests two means of facilitating the adjusunent of breast cancer (BC) patienrs 
(St.ages I, II, and III ) during an in.frequently srudied bur critical tim.eframe-post-radiation therapy (RT). The 
majoriry of women diagnosed with BC receive RT but little nursing research is aimed at understanding and 
facilitating the coping processes following the common experience of RT. This project will provide the first 
critical comparison of two theoretically derived interventions which target the post-RT-coping processes of 
women with BC. The two interventions, which we have pilot tested, target the instrumental and emotional 
coping functions specified by Levantbal's self-regulatory theory. First, Concrete Objective Information (COI) 
add resses unexpected experiences and side effects/symptoms. Second, Expressed Emotional (EE) targecs 
nega tive cancer-related thoughts and emotions which may inhibited . The use of theoretically-based 
information, the C01 improves patients' confidence, underst.anding, and abiliry to apply accurate expectations 
and interventions to specific side effects/symptoms and experiences associated with the end of RT and 
follow-up visits. The EE, by the linguistic integration of expressed emotion and the increased insight of the 
cancer experiences, reduces patients' active inhibition of cancer-related thoughts and emotions. Following 
baselin e measures, one of two interventions or a control condition will be administered during a patient's 
final week of RT at onco logy centers in two different cities . Measures of output and mediating variables will 
be collected via the telephone at 1 week, 4 weeks, and 6 months post-RT. Repeated measures MA.NCOVA 
and hierarchial multiple regression analyses will be used to test the study hypotheses. The interventions 
rested in this smdy have high relevance to oncology nursing practice and will significantly advance 
tlleoretical understanding of coping processes . 
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fostrnctions to Sll!bjects in 
EE foterventioro 
As I mentioned earlier, our study is comparing different ways of helping people cope with the 
experience of cancer and cancer treatment. The program that we've developed for you is 
something new and promising. This program involves writing about your feelings. What I'd like 
you to do is to spend one-halfhouir each day during three of these next four or five days writing 
about your experiences. For exl!.rt1ple, you might choose to write today, tomorrow, and the next 
day; or you might write today, s!ci!P tomorrow and write for one-half hour the following day and 
the dlay after that. 
During the first session, and again on the other two days you write, I want you to spend thirty 
minute s writing. Let go and write about your very deepest thoughts and feelings about your 
cancer and cancer treatment. I'm sure I don't need to tell you that cancer and cancer treatment 
can be a tra umatic experience for many people. Sometimes it's awkward or difficult to discuss 
your feelings with others. We believe that writing about them might be a good way of working 
through anal sorting out these strong and complicated emotion s. m your writing, you might want 
to write about your feelings about your diagnosis, the impact of the disease on your personal 
relationships, or your feelings about radiation treatment. 
Don't worry about your grammar or spelling. These aren't important . What is important is that 
you write for the whole thirty minutes about your deepest thoughts and emotions, especially those 
that you might not have talked about \1/ith anyone. Really try to dig down into your thoughts and 
feelings and explore them in your writing. 
When you are writing at home, if you prefer to use a word processor or typewriter, please do so. 
After you finish wtiting on each of these days, ple:ise complete the !-page questionnaire asking 
about your mood. Put all materials in rhe envelope provide d, seal it, and bring the packet with 
you when you come for your clinic visit on your last day of tre:itme:it. One of the rese:irchers will 
meet you at the clinic to pick up the envelope. 
144 
Day 2 Date. ____ _ 
Please use the pages provided to write about your deepest thoughts and feelings about your cancer and 
cancer treatment especially those that you might not have talked about with anyone. lfyou prefer, you 
can use a word processor or type writer. Do not worry about grammar or spelling. What is most 
important is that you write for 30 minutes. At the end of the half hour, complete the attached rating 
form. 
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Things to Remember as Treatment Ends 
POST RADIATION TREATMENT COPING PROCESSES 
RESEARCH GRANT 
UNIVERSITY OF UTAH 
COLLEGE OF NURSING 
-+'>-
-...} 
Gt::iera.l Edth lvfessage 
Tnis me:;s;:.ge is designed i.O give you informadcn Jbcut rescurces available to you 
anci things that you do now that your radiation the:c.py is e::ciing. Ove:-the pas, few ye1rs, 
the way people ge-:: information about c..nce:-and C:l!lcer tre::it!Ile:::t has c:ianged. i\,fany 
organizations, like the Natonal CJI1ce:-Institute and the A,-nencan. Cance, Soc:ery, have 
information available by ~ompute:-, by telephone, and in print. Both the American Cance:-
Srn;ety and the National Cmce:-In.srimte provide telephone uurnoe:-s for people to call 
who have questions about cancer-. local units of the .A..merican Cance:-Soc:ety also 
provide a variety of se:vices for c.:mce:-patients and maintain libraries of readir1g mate::ials. 
Telephone numbe:-s, Internet compute:-address information, and the address of the nearest 
Ame::ican Can~ Soc::ety Unit are !i~ed in the infor.mat:ion sheet that gees aiong wirh this 
tape. 
Both the Arneric:m Cance:-Socety and the NatioD.2.1 Cance:-I.u.st.irute produce 
v1ritte:i materials for cancer patie:m. You can access these mzte:-ials by calling the 
appropriate org;n:iT>riou. Other sources of in.format.en B:oru bocks er articles fer c:i.nce:: 
patie:its inc!ude public fforaries, bcc~cres, liorc.ries at coileges a.nd 1m.ive,sities witli 
sc:10ols of medicine or nursing, and ti:i.e National Cz.r;ce:-Instirutes. Many pcpular 
mag-::f:ies puoiis.i:! 3.rcic!es abcut c::.r:ce:-a.s weU. y cur led pu.oiic liora.c-f is 1 geed pi2ce 
to loc:.re t.'lese arcic:es. 
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something you won't forger, it is a good ide:! to keep this information in writte:i form. 
You will also want to write down the ']'Pe of c:mce:-you have, whe::i it was diagnosed, and 
the month and ye3! whe::i you finishei ::re:u:me::1t:. 
Tne s+<afi' at the tre:i.tme::it se~g will provide you with information about 
sc:ie::lul.ing your follow-up appoincmems. Some patie:1ts continue seeing the doc:ors and 
nurses from the radiation the.rapy ceme:-for some time. Othe:-s go back. to their He:ilth 
.i\fa.intenance Organization or prim,iry w.re provider for their follow-up care. The 
arrangements re--..ommended to you v.-iil depe:id upon the usual practice followed in your 
tre:itme::it ce:iter and the a.mmge:ne:rt the c:!!lter has with your he:i.lth insurance company. 
If you find that you will be moving out of the area and have bt!!!n getting follow-up care at 
the radiation tre3tment c::::Jter, make S'..U-e to find out if the people h~e re::ummend that 
you contact a radiation tre:itmot center in your new loc:;.tion to arrange your follow -up 
care. 
At ~c::r. follow-up vi.sit, Ill2.ke sure you understand what tests , if any, you need to 
have done before the ne:CT visit. The type oftes. f(Y-Omm.ended depe:tds upon the type of 
c:mcer you bad, how your tre'.ltme:::t we::it, and your othe:- metlic:tl proble:ns. You may or 
may not have things li\e routine biood test.s sc::1eduled as part of your follow-up c;u-e. 
The schedule of foiloW""'JP visirs ibo de7e::1ds on a lot of dirre::e:rt fac:ors. If you 
find thar follow-up vi.sirs are be:..':g 912:!!e:i at ti..""!les wiJ.e:i :,cu 'Nlli be on an e~e=ded trip 
er ii you spur your time ~e,;vee:: ~'us ::e:i :nci mcme:- place , cfoc:.1ss yew- usuai tr3.ve: 
hc.Qits ·:viti.1 ;:he pe:,pie a ,i:ie ,re::::...--;-.e::: ::c :-.,e~ ,o :ie,e:-r.jl'.e ;f your foilow-:.1p visi,s c:m be 
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Rc:nembe:-to ke~;i tr.le:( of c.:ianges in your me:iic:irions or any new he:!lth 
problems so you Qn update your doc:or at e:1c:1 visir. If you have compiica:cd 
medic:nions, it is alwavs a g:ood ide:i to bring the bottles of pills to all your _,;..:;i:s. 1,hle 
sure that all your decors know about e::i.c:i othe: so they can sh.are information. 
You will also want to be sure ycu know who to contact at the Radiation 
--
Tre:mne:1t Center in case :t<Jt! have quemons about any bills or state:::ie::xts you or your 
insuranc~ c::irnparz:, re:~ after your treatme:J.t is c0mpletd. You can get this 
information at the m:epticn desk ifit is not on any cfrhe information sheets ycu re~6:e:i 
at the radiation tre:itme::t ce!lter. 
Y cu will also want to be sur! you are ta.'lcing full advantage ofrhe insurance 
coverc:cge you have. M2.ny pecple don't know about all the be::efus the; are e!ltitled to so 
it is a good to leek over your po!ic-J to make sure tba.t you are submitting ail the bills you 
shoulG. If you have quemons about your insurance coverage, che::( with your employer's 
ber:efhs office or your insur..nce company for assistance in inte::pre-::ing your bene.5ts. __ E 
ycu hc.ve conce:ns about iter:LS your insurance company is or is not paying, you can 
cont.ac: ne radiation trc:!blent ce:1~.::: so they can se::d in a c!aim that was turned down so 
it ge-..s re·,i ewed agmn. Yocr doc!cr m:i.y need to write a letter to explain cnything that 
w:,.s unuxtl about your tre~tme::,. Y-::iu ·;vi] need to c:mt2.c: the do~or-to disc:rss tb..:.s. 
Toe lcc:tl ·Jnit of che ,<l_,.:ie-ic:ll C3.nce:: Scc:e:y .:::.n he:p you :de::itify whic:. age:1c:: in you:-
s:c..te :-egi-1la:es ~~ur~ce c~rnp~es IT you find t.hz.t ycu :ie~~ to file J. c~mpi2l.!"'IL 
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you are imerestd in a voiumee:-cppolluniry, you c:m comae: the loc::.i unit of the 
Ame:ic:ui Cane:=:-Soc:.ecy or the voiuncee:-office :it your loc:tl hospid or at the insrirurion 
wne:-e the tre:itrne:it fac.liry is loc:ited. Ame~c:in Cance:-Soc:e:y volunteers fill :i vane~; 
of jobs. The!:.e inc:ude stuffing e-:ive!opes and an.swe::ing te!e?hones, giving out 
inrorma.cion over the te!ephone about resources in the community, se:ving on the Board of 
Directors oi the Ioctl group, or giving public education programs at meetings in the 
community. Hospital voluntee:s rnay he!p transport patients, de!ive:: flowers and mail, 
greet patients and visitors, assi..'i with pape.-work, or se:ve as visitors for patients in the 
hospital. You may find that the:-e are other organizations in your area whica can use 
voluntee::s to help transport people who do not drive to medical visits,_spe::1d time with 
-p~ple at home, deE:ver equipme::Jt, or make sure that people get a hot me:i..l. 
If you have questions about the mate:-ial in this tape, pie:i.se ask the:n once you tell 
the pe.""Son with you that the tape is fini.5hed. 
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SubJ II_____ Medical Record#--- ------- Consent __ ____ Baseline ____ . 
lntcrvcmion --- --- ln1ervcn1ion -- -- ---
Participant Screening Form 
Post-Radiation Treatment Research 
\amc Date Screened ------ --
:\ge Phone 
-----------
Time of Appl 
Family Histor)' ------ -- ------- Agreed to Participate __ 
Researcher Initi:ils 
------- -
Refused __ (if stated, note rea son) 
Dx Date -- ----- -------
Clinic Site UH StM J COH ~ ___ LDS s Cottonwood 
Physician --------------------
TxStan Date _____ ·------ --
T:c F.nd Date _ _____ Confirmed Date _______ _ In eligib le Criteria 
Duration Under 21 
Dose 2_ Stage O 
Stage---- -------- 3_ Stage JVf}lct s 
Tumor 
--- -----------
4_ Un3ble to ·pc:i.k, write, or read English 
Node 5 _ Rccci, ·ing psychiatric care 
C.--\ Trc :1tmcnt : A., _Chcmo 6 Substanc e abuse 
M:ist 5 S1c111 ( di h Bone \[ 3rro" _ T:irn 7_ Not independent in , df c ir (' 
Other lllnesscs or Condiri ons 8_ Li, in\! in 3n insti1ution3I scning 
~- Co;:ni ti,c deficit 
ifl Pre, inus r :1dL11ion rrca1111c111 
l I _ Pr c, iuu, C.\ (c,ccpt skin ) 
\k dir:11ion, ___ _ _______ _ __ __ __ _____ ____________ _ 
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Subj# __ _ 
Data Line __ _ Tx end date-----
Baseline Demographic Questionnaire 
Directions: Please answer all of these questions accurately. The information you 
provide will be used only for this project and will not be seen by anyone else. 
1. Today's date: 
2. Your age: 
3. Your race or ethnic background: 
4. Your marital status: 
5. Highest grade of school completed: 
6. Your employment status: 
I 
__ years 
10 Asian or Pacific Islander 
20 African American 
3Q Caucasian 
40 Native American 
50 HispanidLatino 
60 Other 
--- ----
10 Single (never married) 
20 Separated or divorced 
30 Widow 
JO Manied 
sO Cobabitating 
10 8th grade or less 
20 Some high school 
.30 High school graduate/GED 
40 Technical school graduate 
sO Some college 
60 College graduate 
10 Master~ degree 
sO Doctora!e degree 
IO Full-tirne(30 hours per \\e ek or more) 
20 Part-time 
; 0 Homemaker 
JO Unemployed 
sO Retired 
GD Disabled 
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Subj# . 
Data Line +------ - Tx end date------
7. What is your religion? 10 LDS 
20 Catholic 
7a. Do you consider yourself to be an 
active or inactive member of your religion? 
(By active, we mean that you attend services 
regularly). 
8. How many people, including yourself, (live in 
in your household? 
9. Have you been hospitalized within 
the past six months? 
9a. If yes, what was the 
reason for your hospital stay(s)? 
10. Have you seen a counselor (therapist, 
psychiatrist, psychologist, social worker) 
at any time since you have been diagnosed 
with cancer? 
l Oa. Was the counseling focused on issues 
related to cancer or was it primarily focused 
on other issues? 
30 Protestant (Christian) 
40 Jewish 
sO Other 
(if you checked any of the above 
boxes, answer 7a) 
60 Not a religious person 
10 Active 
20 Inactive 
__ (#of people in household) 
1DYes 
20 No (skip to ~10) 
10 Yes 
20 No (skip to #11) 
10 Cancer-related 
20 Other issues 
l Ob. Indicate the approximate number of counseling 
sessions you have had since being diagnosed with cancer. 
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Subj # __ _ _ 
Data Line __ _ Tx end date - -- - --
l I . During the past seven days, how often have 
you worried about your cancer? 
12. Do you suffer from any other illness or conditions 
besides cancer ? (e.g., hypertension, multiple 
sclerosis) 
l 2a. Please list all other illnesses or conditions: 
1 CJ Not at a11 
2CJ Rarely 
3(J Sometimes 
4(J Much of the time 
sCJ Nearly all of the time 
1CJ Yes (Ifyes,mswerl 2l ) 
20 No 
13. Please write the month and year you were first diagnosed with breast cancer. 
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Subj # ---- Line Number ___ _ 
PANAS Questionnaire-(State) 
Directions: The words listed below describe different feelings and emotions. 
Please read each item then circle the number that indicates how much you 
have felt that way in the past few days. 
l=not at all 2=a little 3 =moderately 4=quite a bit 5 = extremely 
1. Irritable 1 2 3 4 5 
2. Alert 1 2 3 4 5 
3. Disgusted 
with myself I 2 3 4 5 
4. Inspired I 2 3 4 5 
5. Nervous 1 2 3 4 5 
6. Jittery 1 2 3 4 5 
7. Active 1 2 3 4 5 
8. Afraid 1 2 3 4 5 
9. Guilty 1 .2 3 4 5 
10. Interested 1 2 3 4 5 
11. Distressed 1 2 3 4 5 
12. Excited 1 2 3 4 5 
13. Upset 1 2 3 4 5 
14. Strong 1 2 3 4 5 
15. Enthusiastic 1 2 3 4 5 
16. Scared 1 2 3 4 5 
17. Hostile 1 2 3 4 5 
18. Determined 1 2 3 4 5 
19. Proud 1 2 3 4 5 
20. Attentive 1 2 3 4 5 
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Subj# __ __ _ 
Data Line 
- - --
SICKNESS IMPACT PROFILE 
Code Number : ----------
Baseline questionnaire instructions 
Before beginning this questionnaire , please read the following instructions . 
You have certain activities that you do in carrying on your life. Sometimes you do all of these 
activities . Other times , because of your present illness you may not do these activities in the 
usual way, you may cut some out; you may do some for shorter lengths of time; you may do 
som~ in different ways. We are interested in learning about .fil1Y changes that describe you 
now and are related to your present illness. 
In this questioMaire there will be a good number of statements about how people's health 
could affect their lives. Read all the statements . Think carefully about the statements and be 
sure to check those problems you are experiencing now .. When you read a statement that 
applies to you, describing how your present illness is affecting your daily life, please check it. 
To explain further, we have provided you with an example. You might read the statement "I 
am not driving my car ." If this statement can be answered "yes" because of your health and 
describes you today, you should check it. Also, if you have not been driving for some ti.me 
because of your present illness, and are still not driving today, you should respond to this 
sta teme nt. 
On t he other hand, if you never drive OR are not driving today because your car is being 
repaired, the statemen~ "I am not driving my car" is not related to your health and you should 
not respond to it. If you simply are driving less; or are driving shorter distances , and feel that 
the statement only partially descnoes you, please do not respond to it. 
Remember , we are interested in recent changes in your activities that are related to your 
pre sent illness . 
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Subj# 
-----
Data Line 
---
(HM-0668) 
This group of statements has to do with any work you usually do in caring for your 
. home or yard. Considering just those things that you do, please respond to (check) only 
those statements that you are §.!!!!l describe yo~ today and are related to your state of 
health. 
1. I do work around tile house only for short 
periods of time or rest often. 
2. I am doing less of tile regular daily work 
around the house than I would usually do . 
3. I am not doing fillY of the regular daily work 
around the house that I would usually do. 
4. I am not doing .!IIlY of the maintenance or 
repair work that I would usually do in my 
home or yard. 
5. I am not doing w of the shopping that I 
would usually do . 
6 . I am not doing M!Y of the house cleaning '· 
that I would usually do. 
7 . I have difficulty doing handwork, for example, 
turning faucets, using kitchen gadgets, sewing, 
carpentry. 
8. I am not doing w of the clothes washing that 
I would usually do . 
9. I am not doing heavy work around the house. 
10. I have given up taking care of personal or 
household business affairs, for example, 
paying bills, banking, working on budget. 
(117-054) 
--- (119-044) 
---- (120-086) 
--- (001-062) 
___ · (106-071) 
--- (116-077) 
--- (107-069) 
(111-077) 
(115-044) 
(105-084) 
Che ck here when you have read all statements on this page O 
159 
Subj# ___ _ 
Data Line 
(M-0719) 
Please respond to (check) only those statements that you are!!!!!: describe you today 
and are related to your state of health. 
1. I am getting around only within one building. (134-086) 
2. I stay within one room. (128-106) 
3. I am staying in bed more. (130-081) 
4. I am staying in bed most of the time. (131-109) 
5. I am not now using public transportation. (140-041) 
6. I stay home most of the time. (133-066) 
7. I am only going to places with restrooms 
nearby. (125-056) 
8. I am not going into town. (124-048) 
9. I stay away from home only for brief periods 
of ti.me. (139-054) 
10. I do not get around in the dark or in unlit 
places without someone's help. (121-072) 
Ch~ck here when you have read all statements on this page D 
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Subj# ___ _ 
Data Line 
----
(RP-422) 
This group of sutements has to do with activities you usually do in your free time. 
These activities are things that you might do for relaxation, to pass the time, or for 
entertainment. Please respond to (check) .Q..!!!y those statements that you are~ 
describe you today and are related to your state of health. 
I. I do my hobbies and recreation for shorter periods 
of time. (215-039) 
2. 1 am going out for entertainment less often. (214-036) 
3. I am cutting down on some of my usual inactive 
recreation and pastimes, for example, watching TV, 
playing cards, reading. (207-059) 
4 . I am not doing .fillY of my usual inactive recreation 
and pastimes, for example, watching TV, playing 
cards, reading. (208-084) 
5. I am doing more inactive pastimes in place of my 
other usual activities. (211-051) 
6. I am doing fewer community activities. (216-033) 
7. I am cutting down on some of my usual physical 
recreation or activities. (210-043) 
3. l am not doing my of my usual physical recreation 
or activities. (209-077) 
Check here when you have read :iH st:icements on this page D 
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Subj If----
Dat:a Line __ _ 
RIES 
Instructions: Below is a list of comments made by people after they completed 
treatment for breast cancer. Please circle the number which indicates how often 
ea.ch of these comments was true for you in the past week. 
0 = Not at all 1 = Rarely 2 = Sometimes 3 = Often 
1. I thought about it when I didn't mean to. 0 1 
2. I avoided letting myself get upset when I thought 
about it or was reminded of it 0 l 
3. I tried to remove it from memory. 0 1 
4. I had trouble falling asleep or staying asleep, because 
of pictures or thoughts about it that came into my mind. 0 1 
5. I had waves of strong feelings about it. 0 1 
6. I bad dreams about it. 0 1 
7. I stayed away from reminders of it 0 1 
8. I felt as it hadn't happened or was not real. 0 1 
9. I tried not to talk about it. 0 1 
10. Pictures about it popped into my mind_ 0 1 
11. Other things kept making me think about it. 0 1 
12. I was aware that I still bad a lot of feelings about 
it , but I didn't deal with them. 0 1 
13. I tried not to think about it. 0 
14. Any reminder brought back feelings about it 0 
15. My feelings about it were kind of numb. 0 1 
162 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
2 3 
Subj# _ __ _ 
Data Linc __ _ 
DIS 
(baseline ) 
Since finding out you had cancer, how much have you disclosed your deepest thoughts 
and feelings about having cancer and about your cancer treatment by talking, writing to 
others, or writing in a journal? On a zero to 10 scale indicate the number that best 
represents your responses to this question with zero being "not at all" and ten being 
"complete disclosure ." 
Not ~tall 
0 2 3 4 5 
Completely 
6 7 ·g 9 10 
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